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ABSTRACT

Recovery after central nervous system (CNS) injury has long been a
challenge for clinical investigators. Blockade of the oligodendrocyte-associated
inhibitor Nogo-A has shown great promise in promoting neuronal regeneration,
sprouting, and plasticity, as well as functional recovery in rodent and primate
models of CNS injury. The high expression of Nogo-A in neurons of the postnatal
CNS led us to look for potential roles of this protein in this stage of development.
We hypothesized that postnatal, neuronal NogoA influences the density and
morphology of dendritic spines in the developing CNS, in part, by regulating the
maturation and stability of glutamatergic synaptic input.
To examine the roles of Nogo-A at the excitatory synapse of the neocortex,
we used RNAi directed against Nogo-A and delivered it to the developing rat
sensorimotor cortex via AAV2/8, a neurotropic vector. This resulted in lowered
density of dendritic spines, which are known to house over 90% of excitatory
connections onto pyramidal neurons. This decrease was particularly evident with
thin- and mushroom-shaped spines in dendrites of the apical arbor. A decrease in
protrusions with moderately-wide head widths and very long necks was also
noted. We then used vesicular glutamate transporter 1 (vGlut1) as a marker for
potential excitatory synapses. Knocking down Nogo-A in postnatal pyramidal
neurons of the sensorimotor cortex led to a decrease in the number of vGlut1
xvii

puncta identifying a potential presynaptic partner, in opposition to the apical
dendritic shaft. The decreased vGlut1 in the apical arbor likely represents a loss
of potential synapses that may have a strong influence on direct current injected
into the dendrite.
We further examined regions of transduced cortex via qRT-PCR for
message levels of molecules important for plasticity at the excitatory synapse,
including Neuroligin-1, NMDA receptor subunits NR2A and NR2B, and PSD-95.
We found that mRNA of Neuroligin-1 and NR2B was substantially reduced, with
no changes to NR2A or PSD-95 expression. These results suggest that neuronal
Nogo-A may act to maintain elements of the neocortical excitatory synapse
during development. This finding represents a novel role for Nogo-A in the intact
CNS.

xviii

CHAPTER ONE
OVERVIEW AND HYPOTHESIS

Recovery after brain and spinal cord injury has long been a challenge for
clinical researchers. Neurons in the adult brain and spinal cord cannot grow
more than a millimeter past a lesion site without aid. We now know that the
environment in the injured brain and spinal cord prevents axonal regrowth and
plasticity. This environment is formed by astroglial scarring, chondroitin sulfate
proteoglycans, and oligodendrocyte-associated inhibitory proteins (Gonzenbach
and Schwab, 2008). One of these inhibitory proteins, the first to be discovered,
and the focus of work in our laboratory, is Nogo-A (Caroni and Schwab, 1988).
Thus far, therapies directed against Nogo-A have shown the most promise
in in vivo studies that use animal models of spinal cord injury and stroke. Over
the last twenty years, blockade of the Nogo-A protein has consistently resulted in
neuronal regeneration, sprouting, and plasticity, as well as functional recovery in
animal models of injury (Gonzenbach and Schwab, 2008). Today, Phase II
clinical trials are underway to examine the potential of the anti-Nogo-A antibody
as a treatment for spinal cord injury (Zorner and Schwab, 2010). An estimated
250,000 Americans are currently disabled by spinal cord injury, and there is no
current treatment available. Anti-Nogo-A immunotherapy may also aid in
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enhancing neuroplasticity in people suffering from other injury-induced
neurological conditions, including stroke.
Despite these advances in preclinical and clinical studies, there
is a prevailing deficit in our understanding of the normal
physiological roles of Nogo-A in the intact central nervous system,
and specifically in neurons. A few reports suggest Nogo-A signaling
stabilizes synapses in the intact central nervous system (CNS) (Chivatakarn et al.,
2007; Mingorance-Le Meur et al., 2007; Lee et al., 2008), including neuronal
Nogo-A (Aloy et al., 2006), though the influence of neuronal Nogo-A at the
neocortical excitatory synaptic phenotype has yet to be investigated. This
dissertation will focus on three different properties that comprise the normal
synaptic phenotype: dendritic spines, molecules that are key for normal synaptic
function, and potential presynaptic sites opposing dendritic spines and dendrites.
We will study the effect of Nogo-A on these properties by altering the amount of
Nogo-A in excitatory neurons in the neocortex of normal post-natal rats.

HYPOTHESIS
Postnatal expression of neuronal NogoA influences the density and
morphology of dendritic spines in the developing CNS, in part, by
regulating the maturation and stability of glutamatergic synaptic
input.

3
Specific Aim 1. To determine whether knockdown of neuronal NogoA in postnatal development will alter spine density and influence
spine morphology in neocortical pyramidal neurons. Changes in
dendritic spine density and morphology serve as an indicator of broad changes in
cognitive capacity, both directly, in terms of excitatory postsynaptic potential
(EPSP) processing and calcium buffering, and indirectly, as a predictive correlate
of general cognitive functioning and environmental enrichment. To examine
these parameters, anesthetized neonatal, male rat pups will receive intracerebral
injections of AAV expressing enhanced green flurorescent protein (EGFP) and
short hairpin siRNA (shRNA) directed against Nogo-A (shNogo). At nine weeks
of age, rats will be sacrificed and dendritic spines will be visualized by confocal
laser scanning microscopy. Control rats will receive AAV encoding EGFP only.

Specific Aim 2. To determine whether knockdown of neuronal NogoA in postnatal development will alter the message levels of mature
excitatory synaptic markers. The candidate genes to be analyzed are key
mediators of synaptic functioning and include Postsynaptic density-95 (PSD-95),
N-Methyl-D-Aspartate (NMDA) receptor subunits NR2A and NR2B, Neuroligin1, and Cofilin. The quantity of these molecules has been shown previously to
change in response to synaptic alterations or changes in Nogo-A levels. Adult
rats that have been neonatally injected with AAV will be sacrificed and
microdissected regions of sensorimotor cortex analyzed via quantitative reverse-

4
transcriptase polymerase chain reaction (qRT-PCR) to determine the relative fold
changes in mRNA levels of candidate genes.

Specific Aim 3. To determine whether knockdown of neuronal NogoA in postnatal development will alter the number of potential
excitatory presynaptic sites opposing EGFP-filled dendrites. This direct
study of the molecules that synapse onto transfected neurons will allow for an
examination of presynaptic changes and an approximation of the number of
spines that contain synapses. Adult rats that had been neonatally injected with
AAV will be sacrificed, and the density of vesicular glutamate transporter 1
(vGlut1)-immunopositive puncta will be determined in dendrites of the
sensorimotor cortex.

CHAPTER TWO
REVIEW OF LITERATURE

NOGO-A
Introduction
The CNS environment has long been understood to be inhibitory to
regeneration after injury (Aguayo et al., 1981; Richardson et al., 1984), and
myelin comprises a large part of that inhibitory environment (Schwab and
Caroni, 1988). The Nogo-A protein was the first of these myelin-associated
inhibitory molecules to be isolated, when components of CNS myelin were
separated by polyacrylamide gel electrophoresis; fractions were cut from the gel
and used to generate hybridoma cells that secreted antibodies that would bind to
molecules within the gel fraction (Caroni and Schwab, 1988). Antibodies against
one fraction in particular, named IN-1, neutralized neurite inhibition over myelin
substrates in vitro and facilitated regeneration and recovery after CNS injury in
vivo (Caroni and Schwab, 1988; Bandtlow et al., 1990; Rubin et al., 1994; Guest
et al., 1997; Papadopoulos et al., 2002). The protein that IN-1 was directed
against was eventually purified, sequenced, and named Nogo-A (Chen et al.,
2000).
In vitro studies have shown that Nogo-A destabilizes growth cones and
inhibits cell spreading and migration (Oertle et al., 2003). Cells that are able to
5
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migrate through the CNS, such as stem cells, also degrade myelin-associated
inhibitors (Wright et al., 2007). In the case of migrating tumor cells, this
degradation is accomplished by means of a matrix-metalloprotease (Paganetti et
al., 1988; Belien et al., 1999).
Antibody treatment against Nogo-A has been shown effective after animal
models of CNS injury in a battery of behavioral sensory tests, motor tasks, reflex
responses, and anatomical studies by several independent laboratories
(Gonzenbach and Schwab, 2008). IN-1 immunotherapy has led to axonal
regeneration in rodent and primate models of spinal cord injury via hemisection
(Brosamle et al., 2000; Fouad et al., 2004). Axonal sprouting has been observed
following cortical aspiration lesions and IN-1 administration, as evidenced by
anatomical and electrophysiological studies (Bareyre et al., 2002; Emerick et al.,
2003). IN-1 treatment has also led to axonal sprouting as well as improved
sensory and motor function in rat pyramidotomy and stroke models of CNS
injury (Thallmair et al., 1998; Seymour et al., 2005).
In addition to IN-1, other purified antibodies have also been raised against
Nogo-A and found efficacious in treatment of CNS injury models. Application of
11C7 antibody has resulted in functional recovery and regeneration in primate
models of spinal cord injury (Freund et al., 2006), and recovery when
administered up to two months after occlusive stroke in rats (Tsai et al., 2010).
Use of the 7B12 antibody after photothrombotic and occlusive stroke in rats has
led to behavioral recovery and another mechanism of repair, neuroplasticity
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(Wiessner et al., 2003; Markus et al., 2005). Administration of any of the three
anti-Nogo-A antibodies (IN-1, 11C7, or 7B12) has led to neuroplastic sprouting
and improved cognitive recovery from a rodent model of contralateral neglect
(Brenneman et al., 2008). As defined in this dissertation, neuroplasticity after
injury involves the recruitment of spared neurons to the denervated regions,
whereas regeneration is the regrowth of injured axons to their previous target.

Axon guidance
Nogo-A is one of many axon guidance molecules in the CNS. Several of
these molecules, such as Netrins, Slits, and Semaphorins aid in developmental
pathfinding. These molecules increase the efficiency and accuracy with which
axons locate their synaptic targets (Hong et al., 1999; Galko and Tessier-Lavigne,
2000; Polleux et al., 2000; Whitford et al., 2002). To accomplish this, these
molecules have rigid expression patterns at specific stages of development. For
example, the Slit receptors, named Robo1-3, are expressed on corticospinal tract
(CST) axons in the dorsal funiculus of the spinal cord from E14 to P4, on axons
during CNS midline crossing, with expression levels peaking after decussation
(Sabatier et al., 2004; Sundaresan et al., 2004). Expression patterns of many of
these molecules differ between development and adulthood, forming another
obstacle to repair after CNS deafferentation (Harel and Strittmatter, 2006).
Another class of axon guidance molecules was characterized in the adult
nervous system as myelin-associated inhibitors of axonal outgrowth. These
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molecules include myelin-associated glycoprotein (MAG), oligodendrocytemyelin glycoprotein (OMgp), EphrinB3, and Nogo-A (Mukhopadhyay et al.,
1994; Chen et al., 2000; Wang et al., 2002a; Benson et al., 2005).
To date, therapies directed against all of these molecules have been
examined for treatment of CNS axonal injury. Though anti-Nogo-A
immunotherapy has shown the most promise in animal models of brain and
spinal cord injury, these molecules do work in concert, and ultimately a
combination therapy may lead to the most efficacious recovery from CNS
damage.
Interestingly, several molecules known to repel axons have also been
shown to enhance dendritic plasticity, through various mechanisms specific to
different receptor-ligand systems (Polleux et al., 2000; Whitford et al., 2002;
Morita et al., 2006; Rodenas-Ruano et al., 2006; Aoto et al., 2007; Zagrebelsky et
al., 2010). It is possible that future advances in the field of Nogo-A receptorligand signaling may show Nogo-A to function similarly.

Nogo-A is a member of the Reticulon family
The protein Nogo-A is a member of the reticulon 4 subfamily. This
subfamily has three members, named Nogo-A, -B, and -C. All three isoforms
share the Nogo-A c-terminal structure of 188 amino acids, known as the reticulon
homology domain, which contains a 66 amino-acid sequence known as Nogo-66
(Oertle et al., 2003). Nogo-A, -B, and -C each contain N-termini of decreasing
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length, so that Nogo-A has the longest N-terminus, with over 800 amino acids.
Nogo-A and B are both found in the CNS and, to a lesser extent, in the peripheral
nervous system (PNS). Nogo-B is also found in blood vessels, where it promotes
vascular cell adhesion and migration of endothelial cells during vascular
remodeling events (Acevedo et al., 2004; Miao et al., 2006; Kritz et al., 2008).
Nogo-C is primarily found in skeletal muscle (Oertle and Schwab, 2003).
The reticulons are an evolutionarily conserved family containing a
characteristic endoplasmic reticulum (ER) retention sequence. Members of this
family have roles in exocytosis (Steiner et al., 2004) and cellular stress response
(Tagami et al., 2000; Kuang et al., 2006; Wan et al., 2007; Wojcik et al., 2007).
The majority of Nogo-A molecules present in a cell are found within the ER
(Voeltz et al., 2006).
The N and C-termini of Nogo-A have been shown to be highly
unstructured, possibly existing in different membrane topologies, as shown by
bioinformatics (Li and Song, 2007) and immunohistochemistry (Oertle et al.,
2003; Dodd et al., 2005). As many as 30-60% of eukaryotic proteins may have
long, disordered regions (Ward et al., 2004; Tompa et al., 2006; Li and Song,
2007). This has led to the speculation that different Nogo-A structures, taken
together, may permit ―functional moonlighting‖ within the same cell, i.e. shaping
ER and inhibiting neurite outgrowth (Li and Song, 2007). Nogo-A and –B may
house SH2, SH3, and PDZ domains in their N-termini, potentially allowing
Nogo-A to mediate downstream signaling, similar to the bidirectional signaling
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reported between ephrins and Eph ―receptors‖ (Rodenas-Ruano et al., 2006; Li
and Song, 2007).

Nogo-A Receptors
The Nogo-66 region, found in all three Nogo isoforms, can bind to the
Nogo receptor (NgR1) (Fournier et al., 2001), as can MAG and OMgp. A portion
of the Nogo-A N-terminus also binds NgR1 with high affinity and has been
postulated to modulate Nogo-66 binding and subsequent downstream signaling
in an agonistic fashion (Fig. 1) (Hu et al., 2005). NgR1 has no intracellular
component, and must signal through a multisubunit complex with p75 or Lingo-1
to activate RhoA, which in turn leads to activation of RhoA associated kinase
(ROCK), and increase cytoskeleton contractility through Myosin II (Fig. 1)
(Bandtlow et al., 1993; Loschinger et al., 1997; Schweigreiter et al., 2004;
Sivasankaran et al., 2004; Lowery and Van Vactor, 2009). Studies in dorsal root
ganglion and SH-SY5Y cells have shown Nogo-NgR1 signaling can be suppressed
by NgR1 phosphorylation (Fig. 1) (Atwal et al., 2008). Animals that have had
PirB genetically deleted show delayed closure of the ocular dominance critical
period (Syken et al., 2006), similar to NgR1 and Nogo-A/B knockout mice
(McGee et al., 2005). PirB knockout mice also display normal baseline long-term
potentiation (LTP), as do NgR1 knockout and PirB/NgR1 double knockout mice

11

Figure 1. Nogo-A signaling events. Activated forms of molecules are shown
in black, inactive forms shown in grey. For details, see text. Inset: Domains for
Nogo-A/B/C. For list of abbreviations, see page xiv. Modified from (Lowery and
Van Vactor, 2009; Schwab, 2010).
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(Lee et al., 2008; Raiker et al., 2010) . There is some evidence suggesting PirB
may mediate OMgp signaling in the hippocampus, but the efficacy of PirB
signaling in the neocortex may be impaired by its low expression in this region
(Raiker et al., 2010).
Blockade of NgR1 does not eliminate myelin inhibition of neurite
outgrowth (Kim et al., 2004). Furthermore, the Nogo-66 loop that binds NgR1 is
also present in Nogo-B, which Nogo-A immunotherapy does not target. Finally
studies using directed mutations have shown the N-terminal region of Nogo-A is
a more potent inhibitory region than the Nogo-66 loop (Chen et al., 2000;
Fournier et al., 2001; Oertle et al., 2003; Hu et al., 2005; Gonzenbach and
Schwab, 2008), indicating that at least one other un-identified receptor or
subunit may inhibit axonal outgrowth and cell spreading (Fig. 1). The AminoNogo receptor may also inhibit neurite outgrowth by transactivating Epidermal
growth factor receptor (EGFR) in a calcium-dependent manner, although
treatment with EGF or heparin-bound EGF failed to affect outgrowth (Koprivica
et al., 2005) (Fig. 1).
To a limited extent, the N-terminal region of Nogo-A can achieve these
results by signaling through integrins α3, α4, α5, or β3 (Hu and Strittmatter,
2008). This interaction has either a weak binding affinity, or requires indirect
binding aided by fibronectin or other non-integrin cell surface receptors. The
molecules implicated in the NogoA-NgR1 and integrin pathways have been
studied within the context of the axonal growth cone. Although these presynaptic
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molecules and their downstream mediators are known to affect spine density,
morphology, and the actin cytoskeleton (Gerrow and El-Husseini, 2006; Shi and
Ethell, 2006; Webb et al., 2007; Cingolani and Goda, 2008; Carlson et al., 2010),
no published reports exist to date that specifically investigate Nogo-A-integrin
signaling or downstream NgR1 messengers through the context of Nogo-A
signaling at the spine or synapse. G protein-coupled receptor 50 (GPR50), a
recently characterized protein, has recently become another candidate for an Nterminal specific Nogo-A receptor (Grunewald et al., 2009).

Nogo-A at the Synapse
A few published reports suggest involvement of Nogo-A at synapses and in
development. Nogo-A is localized at pre- and post-synaptic terminals (Lee et al.,
2008; Grunewald et al., 2009; Raiker et al., 2010). Loss of Nogo-A has also been
shown to increase neocortical branching, hasten neurite polarization in vitro, and
delay migration of cortical interneurons in vivo (Mingorance-Le Meur et al.,
2007). Functionally, Nogo-A/B and NgR1 knockout mice have both shown an
extension of the visual critical period in development, as shown by ocular
dominance testing (McGee et al., 2005). Nogo-A has been shown to have a
stabilizing effect on dendritic structure of hippocampal pyramidal neurons
(Zagrebelsky et al., 2010; Delekate et al., 2011).
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Inhibitory synapses in the cerebellum in vivo have been shown to decrease
in density in response to Nogo-A (Aloy et al., 2006), though interestingly, this
change was observed after overexpressing levels of Nogo-A protein postnatally in
Purkinje neurons of the cerebellum. Purkinje cells showed abnormal synapse
morphology and decreased number of axonal contacts onto deep cerebellar nuclei
(Aloy et al., 2006). These effects may be due to downregulation of synaptic
anchoring molecules (Aloy et al., 2006).
NgR1 knockout mice have shown decreased FGF-induced neurite
branching in vitro, enhanced FGF2-dependent long-term potentiation, decreased
hippocampal long-term depression, and altered spine morphologies in vivo (Lee
et al., 2008). Specifically, neurons from the hippocampal CA1 region in the NgR1
knockout mice displayed a decrease in mushroom and thin spines and an
increase in stubby spines, but no change in total spine density (Lee et al., 2008).
This same laboratory recently showed that Brain-derived neurotrophic factor
(BDNF) activation of the pAKT/mTOR pathway may be inhibited by Nogo-66
(Raiker et al., 2010). Other laboratories also showed that the actions of BDNF
can be opposed by Nogo signaling (Endo et al., 2007; Chytrova et al., 2008).
Neurotrophins can also override the inhibitory effects of Nogo on neurite
outgrowth by cAMP-PKA-CREB mediated mechanism (Hannila and Filbin,
2008; Joset et al., 2010). These findings have led to the hypothesis that Nogo-A
signaling works in equilibrium with growth factors to fine tune the crucial
process of use-dependent neuronal plasticity.
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Neocortical Expression of Nogo-A
Throughout all stages of development, Nogo-A is expressed on
oligodendrocytes (Huber et al., 2002). Nogo-A is also present in embryonic
development within radial glia and at the leading process of migrating neurons
(Mingorance-Le Meur et al., 2007). Human embryos also express Nogo-A in
postmitotic cells of the cortical plate (Al Halabiah et al., 2005). Expression in the
white matter decreases after early postnatal development, though protein
expression persists in pyramidal neurons of the adult neocortex, in both humans
and rats (Buss et al., 2005; Cheatwood et al., 2008). Within these neurons,
Nogo-A is present in postsynaptic sites in dendrites and spines of cortical
neurons (Pradhan, 2007; Grunewald et al., 2009).

DENDRITIC SPINES
Dendritic spines house the majority of excitatory inputs onto pyramidal
neurons (Gray, 1959). Spines act as individual compartments on the dendrite,
buffering calcium dynamics and regulating electrophysiological and molecular
signaling. Long-term potentiation (LTP), a form of memory on the cellular level,
has been shown to induce actin to change spine shape, increasing the width of the
spine head and decreasing the length of the spine neck. At the same time, the
concentration of glutamate receptors increases in the postsynaptic density (Yuste
and Bonhoeffer, 2001).
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Spine density per length of dendrite and individual spine morphology have
been shown to change in response to development, environmental changes such
as enrichment or hibernation, usage and experience, and hormones (Popov et al.,
1992). At the same time, large spines have been shown to change very little, and
sometimes not at all throughout the adult life of an animal (Grutzendler et al.,
2002). Various forms of developmental disability, such as Down‘s syndrome and
Fragile X syndrome (Dierssen and Ramakers, 2006), are associated with deficits
in spine density and with an increased number of filopodial protrusions (Fig. 2)
on pyramidal neurons of the neocortex and hippocampus.
Several theories exist with regards to formation of new spines. The first
holds that after repeated exposure to an LTP-inducing stimulus, over a period of
hours the spine head can form a second synapse on an axon, and this second
synapse may in turn lead to the formation of another spine (Segal, 2005). This
conjecture is not without controversy, as synapses onto bifurcated spines are
rarely from the same neuron (Fiala et al., 2002b). A second mechanism for new
spine development is that spines may arise from synapses onto the dendritic
shaft (Fiala et al., 1998; Ethell and Pasquale, 2005). A third possibility is that
filopodial extensions probe the environment for molecular signals resulting from
changes in neurotransmitter release, and then form synapses with active axon
terminals (Holtmaat et al., 2006; Nagerl et al., 2007).
The question of whether changes in spine morphology are a direct or
indirect cause of plasticity is another area of scientific debate. There is no
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Figure 2. Common morphologies of dendritic protrusions. (A) Shown
from top to bottom is an idealized filopodium, stubby, thin, mushroom, and
bifurcated spine. Classification is based on the relationship of the spine head to
the neck diameter, adapted from (Lippman and Dunaevsky, 2005) (B)
Representative EGFP-filled dendritic segment with spine morphologies, from
AAV-transduced tissue imaged at 63x magnification on laser scanning confocal
microscope. Note that filopodia were not counted as spines, and that spine
morphology is truly a continuum. The categories shown here are used to
generalize the differences between spines.
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question that the shape of a spine will affect its function by controlling current,
calcium dynamics, and by filtering membrane potential. Larger spines inject
larger currents into the dendrite, thereby affecting downstream signal processing
(Matsuzaki et al., 2004). Also, the length of the spine neck controls calcium
diffusion from spines and electrically filters postsynaptic potential (Yuste, 2010).
However, the environmental and developmental conditions known to affect spine
density listed above are likely to also lead to wide-scale changes in synaptic
plasticity. The same endocytic machinery that controls the amount of membrane
at the postsynaptic site is also essential for insertion of proteins such as AMPA
receptors into the postsynaptic density (PSD) (Wang et al., 2008). The
concentration of AMPA receptors is a known requirement of synaptic maturation
(Nusser et al., 1998). It is possible that spines act as diffuse computational
devices, endowing circuits with the ability to perform Boolean logic, but at the
very least the density and morphology of spines can serve as an indicator of
general synaptic function.

POSTSYNAPTIC MOLECULES IMPORTANT FOR SYNAPTIC
FUNCTION
PSD-95 is localized to active synapses and serves to anchor many key
elements of synaptic transmission, including glutamate receptors and the actin
cytoskeleton (Blanpied et al., 2008; Chen et al., 2008). Also known as DLG4, it is
considered an excitatory synaptic marker.
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The NMDA receptor is a type of ionotropic glutamate receptor whose
participation in the post-synaptic density substantially regulates synaptic
plasticity, including LTP. NMDA receptors have the highest calcium permeability
of all glutamate receptors, but they require voltage-activation to remove a
magnesium block of the ion channel. The channel will only open at a synapse
that has recently received an excitatory post-synaptic potential, making the
NMDA receptor a molecular coincidence detector and allowing for a kind of
computation in the postsynaptic neuron (Yuste, 2010).
The regulation of NMDA receptor channel activity occurs through widely
varied means, suggesting that this receptor has a significant role in information
processing. The complexity of this regulation includes, but is not limited to,
magnesium blockade, localization to synaptic or extrasynaptic sites,
phosphorylation by molecules such as Ca2+/calmodulin-dependent protein
kinase 2 (CamIIK), and expression of different subunits. There are five NMDA
receptor subunits: NR1, NR2A, NR2B, NR2C, and NR2D. Changes in NR2
subunit expression levels have been reported in the developmental maturation of
synapses in the thalamus, somatosensory cortex, and cerebellar granule neurons
(Liu et al., 2004; Fu et al., 2005). For example, from the peak to the closure of
the visual cortex critical period, the expression of NR2A predominates over NR2B
(Cho et al., 2009). Activity or deprivation-induced plasticity in adulthood has
also been linked to expression levels of these subunits (Yashiro and Philpot,
2008; Corson et al., 2009).
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Neuroligins are postsynaptic anchoring molecules that help maintain the
synaptic cleft through the presynaptic binding to presynaptic Neurexins. Many
such pairs of adhesion molecules collectively maintain the synaptic cleft, much
like the many weak interactions that hold two pieces of Velcro together.
Additionally, Neuroligins have demonstrated transsynaptic control of vesicular
release via Neurexins (Wittenmayer et al., 2009; Stan et al., 2010). For example,
Neuroligin-1, which is enriched at excitatory synapses, may control presynaptic
vesicle release via β-Neurexin‘s links to Munc18 via Cask-Mint1 interactions
(Futai et al., 2007).
Altered Neuroligin-1 expression in rodents has been linked to changes in
LTP, short-term plasticity, spatial memory, fear memory and social behavior
(Futai et al., 2007; Kim et al., 2008; Blundell et al., 2010; Dahlhaus and ElHusseini, 2010; Dahlhaus et al., 2010), probably due to Neuroligin-1‘s ability to
expedite activity- and growth factor-mediated synaptogenesis (Nam and Chen,
2005; Xu et al., 2010). Expression levels of Neuroligin-1 have also been shown to
directly affect the ratio of excitatory to inhibitory synapses; similar effects have
been produced with altered levels of PSD-95 (Gerrow et al., 2006; Dahlhaus et
al., 2010; Levinson et al., 2010). This role in the specification of synapses is
largely thought to be mediated by interaction between Neuroligin-1 and PSD-95—
or gephryn, in the case of Neuroligin-2—(Chubykin et al., 2007; Barrow et al.,
2009; Levinson et al., 2010). Neuroligin-2, which is concentrated in inhibitory
synapses (Graf et al., 2004; Varoqueaux et al., 2004), is one of the synaptic
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markers that displayed downregulation in cerebellar Purkinje neurons that
overexpressed Nogo-A (Aloy et al., 2006).

RNA INTERFERENCE
RNA interference (RNAi) suppresses or degrades RNA transcripts, thereby
hindering production of the encoded proteins. RNAi allows for higher levels of
regulation in producing the vast amount of differentiation seen in the adult. The
study of endogenous RNAi has expanded in recent years, and the molecules have
been found to have major roles in nervous system disorders and development.
Various neurological conditions are linked to disruption of RNAi machinery,
including Tourette‘s syndrome, various brain tumors, and the alterations in spine
development and Fragile X mental retardation protein (FMRP) function in fragile
X syndrome (Jin et al., 2004; Abelson et al., 2005; Chen and Stallings, 2007;
Corsten et al., 2007). In development, RNAi regulates neural patterning,
outgrowth, spine development, apoptosis, circadian rhythms, lineage
differentiation, and proliferation (Schratt et al., 2006; Krichevsky, 2007;
Visvanathan et al., 2007). RNAi can suppress alternate mRNA splice variants.
For example, downstream effectors of the MicroRNA (miRNA) miR-124 can
suppress non-neuronal genes expression and activate neuronal gene
transcription, including their splice variants, through an intricate negative
feedback cycle (Visvanathan et al., 2007; Makeyev and Maniatis, 2008).
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The RNAi process is evolutionarily conserved across kingdoms, and has
been documented in animals, plants, and, to a limited extent, fungi (Saumet and
Lecellier, 2006). RNAi has two primary roles in the cell, as a defense mechanism
against viruses, and as a means of post-transcription gene regulation, where a cell
can transcribe both a message and a means to break down that message. In
keeping with these two well-documented functions of RNAi, there are several
methods by which RNAi may work, including nonspecific degradation of all
mRNAs (Sledz and Williams, 2004). Most often, researchers use RNAi to silence
the transcripts of one specific gene via short RNA duplexes.

RNAi Machinery
As seen in Figure 3, the first step of the RNAi pathway involves
transcription from DNA of pri-miRNA, a stem-loop structure typically flanked by
nucleotides of varying lengths. These flanking nucleotides on the pri-miRNA are
cleaved at the stem-loop in the microprocessor complex by the enzyme Drosha, to
form a hairpin structure of ~70 nucleotide (nt), known as pre-micro-RNA (premiRNA). Pre-miRNA can be shuttled out of the nucleus via exportin-5-RANGTP
(Rana, 2007). Once released into the cytoplasm, the enzyme Dicer can further
process pre-miRNA into a 22nt duplex structure known as mature miRNA. This
cleavage by Dicer leaves a 2nt overhang at the 3‘ end and a phosphate group at
the 5‘ end (Kim et al., 2005). Mature miRNA is unwound by RNA-induced
silencing complex (RISC) at the end of the duplex with the lowest thermodynamic
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Figure 3. Endogenous intracellular RNAi pathway and tools that can
utilize it for therapeutic purposes or to study neuronal function. Modified from
(Davidson and Boudreau, 2007).
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stability, typically the end with the highest A-T to G-C ratio (Khvorova et al.,
2003). The 3‘ strand at this end is degraded, while the 5‘ strand is irreversibly
bound to RISC, where it can then bind complementary segments of mRNA. If the
strand is a perfect match, Dicer then cleaves the message strand into 23nt
segments. These segments are recognized by cellular nucleases and further
cleaved into individual nucleotides and, in so doing, prevent protein synthesis
(Davidson and Boudreau, 2007).
By leaving the miRNA strand intact and irreversibly bound to Dicer, a
single miRNA duplex can inhibit protein synthesis of numerous mRNA
transcripts. RISC-miRNA complexes can sometimes be passed down to progeny
cells and even germline cells (Carmell et al., 2003). This amplification can ideally
silence a large proportion of message copies, and the protein is considered
‗knocked down‘. mRNA strands with a small number (less than three) of
imperfect matches have been documented to bind the complimentary strand in
the RISC but are usually not cleaved (Bagga et al., 2005). In this instance, the
miRNA-RISC can bind a single copy of the message, thereby halting access to
ribosomes. However, if the cell has other copies of the same mRNA, then these
messages are still available for protein synthesis. When this occurs, the message
is termed repressed, but not silenced.
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Synthetic RNAi as a Tool for Neuroscientists
RNAi is frequently used in neuroscience and other fields as a technique to
study effects of proteins, and as gene therapy, aiming to suppress proteins that
cause or exacerbate diseases. Synthetically introduced pri-miRNA, pre-miRNA,
or miRNA duplexes are referred to as artificial miRNA, short hairpin (shRNA), or
short interfering (siRNA) RNA duplexes, respectively. These exogenous forms of
RNAi can utilize the same machinery as mature miRNA, though they may require
modification to achieve efficacy, either by design or by the cells transfected. For
example, chemically synthesized siRNA duplexes are capable of undergoing
phosphorylation by cellular enzymes at the 5‘end (Rana, 2007). However, the
cell has no machinery to form the 2nt overhang at the 3‘end. This change must
be introduced in the design of the siRNA. The overhang is not required for
silencing but aids incorporation into the RISC, and usually results in higher
knockdown efficacy (Kim et al., 2005; Marques et al., 2006; Rana, 2007).
The neuroscience community has capitalized on RNAi applications in
many ways, using the technique to study effects of specific genes (Shalizi et al.,
2006) and gene therapy studies for inherited neurological conditions (Cearley
and Wolfe, 2007; Denovan-Wright et al., 2008). Therapeutic RNAi studies have
been performed in rodent models of Huntington‘s disease, lipid storage diseases,
Alzheimer‘s disease, and amyotrophic lateral sclerosis, amongst others (Xia et al.,
2004; Harper et al., 2005; Rodriguez-Lebron et al., 2005; Denovan-Wright et al.,
2008). With several phase I and II clinical trials investigating siRNA in
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neuroscience-related applications, such as macular degeneration (Cearley and
Wolfe, 2007; Denovan-Wright et al., 2008), RNAi remains a possibility in the
field of genetic therapy.
Another prominent application includes the knockdown of specific genes
to study their functions. For example, those interested in identifying various
regulators of dendritic spine development and maintenance have utilized RNAi to
identify many cytoskeleton effectors necessary for those roles, such as the Rac1
GEF Tiam1 (Tolias et al., 2007), p190 RhoGAP and Rho GTPase (Zhang and
Macara, 2008), drebrin and Ras (Biou et al., 2008), Arf GAP centurin alpha1
(Moore et al., 2007), ARF6 and EFA6A (Choi et al., 2006), the synaptic adaptor
protein GIT1 (Zhang et al., 2005), and the PKC target MARCKS (Calabrese and
Halpain, 2005). The Sabatini group found that activation of the interferon
response can decrease spine density and length (Alvarez et al., 2006). On the
other hand, loss of RNAi machinery itself has been found to result in abnormally
long dendritic spines, up to 12 microns in length (Davis et al., 2008). This
suggests that the endogenous miRNA pathway and gene-specific knockdown are
critical for normal spine maintenance.
Predicting efficacy of siRNA sequences can be complicated. Different
segments of a single mRNA transcript will have different accessibility to siRNA
sequences, due to attached proteins or mRNA folding into secondary or tertiary
structures (Brown et al., 2005; Westerhout and Berkhout, 2007). This has led to
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the common practice of screening different siRNA sequences in vitro to identify a
sequence with optimal knockdown efficiency (Overhoff et al., 2005).
A considerable caveat when using siRNA as a tool to investigate protein
function involves potential changes to activation states of off-target genes, which
include any gene other than those intended for knockdown. Experimental
interpretation can be confounded by suppression of unintended genes due to
sequence homology. siRNA can also induce expression of off-target genes
through the interferon cascade, in a dose-dependent manner (Persengiev et al.,
2004; Judge et al., 2005). Other off-target effects can be induced by detection of
double stranded (ds) RNA, either by the PKR or 2,5-oligoadenylate synthetase
pathways. Both of these latter enzymes can suppress transcription while
simultaneously activating genes such those of the interferon pathway, the first
line of viral defense in a host cell (Dong and Silverman, 1997; Sledz et al., 2003).
Segments of dsRNA over 33nt long can activate an enzyme known as ds-RNAdependent protein kinase (PKR) (Manche et al., 1992). Once active, PKR can
then phosphorylate eIF2, prohibiting methionine-tRNA from binding to
ribosomes and, as a result, globally inhibit all protein production (ZamanianDaryoush et al., 1999).
Interferons are a family of cytokines that can activate immune cells such as
macrophages, promote immunity against viruses in nearby cells, and influence
cellular proliferation and apoptosis. Interferons transduce signals through
receptors at the cell surface and on endosomes, using the Janus Kinase-Signal
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Transducer and Activator of Transcription (JAK-STAT) pathway of transcription
factors to induce changes in at least 300 genes (Der et al., 1998). Interferon
activity can be measured by a variety of methods, including systemic cytokine
levels, microarrays, proteomics, and, in the CNS, microglia activation. General
rules of thumb have been elucidated for specific structures and sequences that
tend to be more predisposed to set off the Interferon response than others
(Birmingham et al., 2006). For example, siRNA sequences of over 23nt have
been shown to induce the Interferon response more than shorter siRNAs
(Hornung et al., 2005). It has also been reported that blunt-ended structures
were worse than structures with 2nt 3‘ overhangs (Marques et al., 2006), which
Dicer-mediated cleavages normally produce. siRNA duplexes with weak
thermodynamic strand preference double the risk of these events by allowing
RISC to unwind both strands with equal ease (Khvorova et al., 2003).

CHAPTER THREE
POSTNATAL KNOCKDOWN OF NEURONAL NOGO-A LEADS TO A
DECREASE IN APICAL DENDRITIC SPINE DENSITY
IN THE NEOCORTEX

ABSTRACT
The myelin-associated protein Nogo-A is a well-known inhibitor of axonal
regeneration and compensatory plasticity, yet functions of neuronal Nogo-A are
not as clear. The present study examined the effects of decreased levels of
neuronal Nogo-A on dendritic spines of developing neocortical neurons.
Decreased Nogo-A levels in these neurons resulted in lowered spine density,
particularly with thin- and mushroom-shaped spines in the apical arbor. Spine
density and morphology in the basilar dendritic tree was unaltered by loss of
Nogo-A. These results suggest a role for neuronal Nogo-A in maintaining a spine
phenotype in neocortical pyramidal cells.
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INTRODUCTION
The Nogo-A protein is a potent suppressor of neuronal outgrowth in the
intact (Montani et al., 2009) and injured (Gonzenbach and Schwab, 2008) CNS.
Anti-Nogo-A immunotherapy after ischemic stroke in the adult rat induces
axonal remodeling and functional recovery, and also leads to enhanced dendritic
arborization and increased spine density in pyramidal neurons of the
contralesional neocortex (Papadopoulos et al., 2006). This finding of effects on
spine density led us to investigate the role of Nogo-A in neocortical pyramidal
neurons of the undamaged CNS, to determine if neuronal Nogo-A plays a role in
dendritic spine development.
Earlier studies of neuronal Nogo-A have shown that expression levels are
high in embryonic and neonatal development, particularly in populations such as
Purkinje neurons of the cerebellum, pyramidal cells of the hippocampus, and in
layer V pyramidal neurons of the sensorimotor cortex of the rodent (Huber et al.,
2002; Mingorance et al., 2004; Mingorance-Le Meur et al., 2007). Temporal
expression patterns of Nogo-A throughout embryonic and neonatal development
indicate that the molecule may participate in processes beyond inhibition of
outgrowth and plasticity (Josephson et al., 2001; Caltharp et al., 2007). Indeed,
recent work has suggested that Nogo-A is involved in neuronal branching,
neuronal migration, and synapse stabilization (Aloy et al., 2006; Mingorance-Le
Meur et al., 2007). Specifically, cultured neurons from mice lacking expression of
Nogo-A as well as the other Nogo isoforms B and C showed enhanced axonal
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branching in vitro (Mingorance-Le Meur et al., 2007). In vivo, these mice
displayed delayed interneuron migration during neocortical development
(Mingorance-Le Meur et al., 2007). Also, Nogo-A overexpression in cerebellar
Purkinje neurons from postnatal day 7 to adulthood led to a decrease in stability
of inhibitory synaptic contacts, a decreased number of synapses overall, and
deficits in motor learning and coordination (Aloy et al., 2006).
In order to directly assess the role of neuronal Nogo-A in dendritic spine
development in vivo, we used a Nogo-A knockdown approach mediated by
shRNA, delivered by an adeno-associated virus serotype 2/8 (AAV2/8). AAV2/8
is ideally suited for targeting neuronal Nogo-A because approximately 95% of
transduced cells in the CNS are neurons (Allocca et al., 2007; Dodiya et al.,
2009). Transduction of oligodendrocytes, the only other cell in the intact CNS
that is Nogo-A positive, is negligible (Broekman et al., 2006). Our study
demonstrates that shRNA knockdown of neuronal Nogo-A in early postnatal
development leads to lowered spine density, particularly with thin and
mushroom-shaped spines in apical dendrites of adult neocortical pyramidal
neurons. We saw no changes to spines in the basilar arbor of these neurons.
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METHODS
AAV production
Plasmids
Plasmids to be used included Nogo-A shRNA, helper plasmid, and
AAV2/8. One μg of each plasmid was added to Escherichia coli DH5a bacteria
(Invitrogen). Transformation involved a 20 minute incubation period over ice,
followed by 45 seconds at 37˚C. The bacteria were grown in Luria broth (LB),
and mixed in eppendorf Thermomixer at 600 rpm for 30-90 minutes. Bacteria
were plated and incubated overnight at 37˚C. The following day, a single clone
was transferred to 2 mL LB containing ampicillin (100 µg/mL), incubated with
agitation overnight, transferred to flasks containing 200 mL amp-LB, and
incubated with agitation overnight again. Plasmids were isolated by anionexchange columns, per maxiprep protocol (Qiagen). Plasmid concentration was
estimated by absorbance at UV 260:280 λ. Plasmid identity was verified with
restriction enzyme digestion followed by agarose gel electrophoresis and
sequencing.

Production
HEK-293 cells (Invitrogen) were grown in Dulbecco‘s modified Eagles
medium (DMEM) with 10% fetal bovine serum and 100 U/mL
penicillin/streptomycin to 70-90% confluence on 15 cm dishes. Cells were
washed twice in Phosphate-buffered saline (PBS), and 18 mL of DMEM:5%
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Modified Bovine Serum (Virapak transfection kit, Stratagene) +
penicillin/streptomycin (100 units/mL) media added to each plate. Briefly, 25 μg
of each of the three plasmids were mixed with 100μL of 2.5 M CaCl2, followed by
750 μL of 2X 2×N,N-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid (BES)buffered saline. The mixture was incubated for 10 minutes at room temperature.
1.8 mL of this solution was added drop-by-drop to each plate, and plates were
gently swirled. To assist transfection, incubator CO2 levels of were dropped to 3%
for 12-18 h. After this time, cells were washed twice and media was replaced.
Three days post transfection, cells were washed, harvested, and lysed by 3 cycles
of freeze/thaw. After the third thaw cycle, lysates were incubated at room
temperature for 30 minutes in benzonase (50 U/mL), and then centrifuged at
3700 g for 20 minutes.

Purification
An iodixanol purification gradient was created according to (Zolotukhin et
al., 1999). Briefly, Quick-seal Ultra-clear 28x89 centrifuge tubes were filled with
5 mL of 60% iodixanol with 30 µL of a 0.5% phenol red stock solution, 5 mL of
40% iodixanol in PBS-MK buffer, 6 mL of 25% iodixanol in PBS-MK buffer with
60 µL of phenol red stock, 9 mL of 15% iodixanol, and 15 mL of the crude lysate.
All solutions were added dropwise, by Pasteur pipette, with special care taken to
avoid mixing. Tubes were sealed and centrifuged at 18˚ for 1 hour at 350,000 g.
An 18-gauge needle was used to aspirate 5 mL of the 60:40 interface. The virus
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was then concentrated by centrifugation through Amicon Ultra-15 100 K filter
(Millipore). The buffer was exchanged to PBS through repeated dilutions and
centrifugations.

Titre estimation
Primate fibrosarcoma HT-1080 cells were cultured in 6-well plates to 80%
confluence. AAV2/8 was serially diluted and added to cultures. On the fourth
day, media was replaced. Fluorescent cells were counted at four, five, and six
days post infection with aid of a heamacytometer. Viral titre was estimated from
an average of counts on these three days. Stocks of AAV-Nogo, AAV-Luciferase,
and AAV-EGFP were estimated to be 2x109 infectious particles / µL.

Animals
Long-Evans Black-Hooded male rats (Harlan) were used throughout the
study. At postnatal day 5 (P5), litters were size-matched to 8 pups. At weaning
(P23), males were housed two or three to a cage, allowed free access to food and
water, and maintained on a 10h/14h light/dark cycle. This study was conducted
using protocols approved by the Edward Hines Jr. VA Hospital Institutional
Animal Care and Use Committee in accordance with National Institutes of Health
principles of laboratory animal care.
P3 pups were cryoanesthetized, a 1 cm incision was made in the scalp, and
the pup was placed in a neonatal stereotaxic device. Two craniotomies were
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performed. Injection coordinates are given in Table 1. With these coordinates,
EGFP+ cells were observed in both the hippocampus and sensorimotor cortex. A
32 gauge microsyringe (Hamilton) was lowered into the brain, and left in situ for
one minute. 250 nL of virus was slowly injected into each site over a period of
one minute. The needle was left in place for one minute before gradual removal
over the course of one minute. Multiple injections were performed
simultaneously to minimize the time spent under anesthesia. Animals were
warmed by a halogen lamp and skin was sutured with 5-0 monofilament. A small
bubble of tattoo ink was injected under the skin of the dorsal paw(s) for
identification. Each neonate was away from the dam for approximately two
hours.

Verifying Nogo-A knockdown
HEK293 cells were transfected with decreasing amounts of shNogo
plasmid and equal amounts of Nogo-A plasmid using Polyfect Transfection
Reagent in accordance with manufacturer‘s instructions (Qiagen). At the same
time, an identical set of plates were also transfected with shLuciferase plasmid in
equimolar amounts to shNogo, to control for promoter competition. Cells were
lysed and harvested at three days post transfection. All experiments were
replicated at least three times.
SDS-PAGE and western blotting were performed as previously described
(Kelleher and Long, 1992). Briefly, 20 mg of cell protein lysates were
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Right
Needle positioned at 16º angle to allow
space for both needles

Left

Posterior

Lateral

Ventral

Posterior

Lateral

Ventral

0.1

1.7

1.8

0.3

2.2

1.8

0.8

1.8

1.8

1.1

2.3

1.9

Table 1. Neonatal stereotaxic coordinates for AAV-injection.
Coordinates are measured in mm with respect to bregma.
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electrophoresed through a SDS-polyacrylamide gel and transferred at 55 V for 90
minutes to a polyvinylidene difluoride membrane. Membranes were dried to
visualize transfer efficiency, then rewetted in methanol. Membranes were
incubated overnight at 4˚C with primary monoclonal antibodies (1:750 diluted in
TBS-Tween:5% powdered milk for mouse 11C7, 1:5000 dilution as before for
rabbit anti-GAPDH antibody). The membrane was washed with PBS and
incubated with an alkaline phosphatase conjugated secondary antibody specific
to the primary species (1:5000 dilution; Pierce) for 2 hours at room temperature
before washing and reacting the membrane with chemiluminescent substrate
(Pierce). Dose-dependent trends band pattern were visualized from three
replicate experiments.
To confirm Nogo-A knockdown in vivo, animals were injected as described
above, anesthetized (sodium pentobarbital, 1 mg/kg, i.p.) and transcardially
perfused with 4% phosphate-buffered paraformaldehyde. Brains were
cryoprotected for 24 hours in 30% sucrose solution, sectioned on a cryostat at
40μm, and stored in PBS with azide. Free-floating sections were incubated with
blocking solution, Tris-buffered saline (TBS)-0.1%TritonX-100:10%NGS for 1.5
hours, followed by primary antibody overnight in 5% NGS (11C7, 1:750 diluted in
TBS:0.1% Triton-X:5% NGS, Novartis). Sections were washed in TBS0.1%Triton-X-100, and incubated in secondary antibody (Rabbit-anti-mouse
Alexa Fluor 594, Molecular Probes A21125, diluted 1:1000, as above) for 2 hours
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at room temperature. Sections were again washed, mounted onto slides, and
coverslipped.
Ten to twelve 0.5 µm-thick stacks were taken at 63x magnification on a
laser-scanning confocal microscope. Three animals were examined per group,
with at least fifty EGFP+ cortical cells counted per animal. Of these transduced
cells, the total number of Nogo-A immunopositive cells was also counted. The
number of double-labeled cells was expressed as a percentage of the total number
of transduced cells.

Dendritic spine imaging via laser-scanning confocal microscopy
Rats were anesthetized (sodium pentobarbital, 1 mg/kg, i.p.) and
transcardially perfused with 4% phosphate-buffered paraformaldehyde. Brains
were removed, cut into 200 μm thick sections with a vibratome, mounted onto
slides and coverslipped. Images were captured with a confocal microscope and
analyzed using NIH ImageJ. Five terminal, 2nd order or higher, EGFP-filled
pyramidal dendrites were imaged per animal at 63x water-immersion objective
on a scanning laser confocal microscope with 4x zoom. Dendrites from the
sensorimotor cortex were chosen from the basilar arbor and from the apical arbor
proximal to the tuft of layer V neurons. All protrusions along a 10 µm segment of
dendrite were counted from five different neurons per animal. Filopodia
dendritic protrusions that did not show a clearly identifiable spine head, as
described in (Harris et al., 1992), were counted and each listed separately. For

39
morphology analysis, maximum head diameter and length were measured for
each spine. Protrusions were classified according to (Lippman and Dunaevsky,
2005), as seen in Figure 2. Six rats per group were utilized for basilar spine
analysis. To analyze apical spines, 6 and 10 rats were used from the AAV-EGFP
and AAV-shNogo groups, respectively. For basilar spine evaluation, 6 animals
were used per group.

Statistical analyses
Unless otherwise stated, Prism 4 for Windows (GraphPad Software, Inc.)
was used to analyze all data via the two-tailed Student‘s t-test. In all cases, p <
0.05 was regarded as statistically significant.
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RESULTS
Recombinant virus, AAV-shNogo, mediated in vitro and in vivo NogoA gene knockdown.
Neocortical layer V pyramidal neurons were transduced following AAV
injection (Figs. 4 and 5) into the presumptive primary sensorimotor cortex of P3
rat pups. While we did occasionally observe EGFP-positive cells that resembled
astrocytes, approximately 95% of cells transduced had a neuronal morphology
(Fig. 6A-H). Pyramidal neurons transduced with the control vector, AAV-EGFP,
showed immunoreactivity for Nogo-A, while very few pyramidals from the AAVshNogo group showed any Nogo-A immunostaining (Fig. 6). The average percent
of double-labeled cortical cells was 38.3 ± 3.8 in the control vector group, and 9.7
± 7.7 in the AAV-shNogo transduced group (p=0.029; Fig. 7B), indicating a 75%
decrease in the number of transduced, Nogo-A positive neurons. HEK-293 cells
transduced with Nogo-A and shNogo-A showed reduction in Nogo-A protein as
the dose of shNogo-A plasmid increased (see Fig. 7A for a representative blot).
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Figure 4. Representative viral spread from two rAAV2/8 treated rats.
Examples of moderate and high viral spread shown at left, and right, respectively.
Blue color indicates regions of EGFP signal, as detected at 5x magnification.
Figure adapted from Paxinos and Watson, 2006.
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Figure 5. Representative AAV2/8-EGFP transduction in sensorimotor
cortex. The green color indicates a virally transduced neuron (EGFP). Note the
layer of transduced pyramidal neurons. Pictures were taken at 5x, 20x, and 63x
magnification. 63x photos were taken on scanning confocal microscope.
Modified from Paxinos and Watson, 2006. Scale bar indicates 10 micrometers.
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Figure 6. Representative in vivo knockdown mediated by
recombinant virus in neurons. A-D, J-L When injected in the primary
sensorimotor cortex of neonatal rats, AAV-EGFP transduced neurons (arrows
point to examples) showed Nogo-A immunoreactivity 6 weeks after injection.
However, the AAV-shNogo transduced neurons showed negligible Nogo-A
immunoreactivity (E-H, M-O). j-o Scanning confocal microscope images, at a
higher magnification, demonstrate loss of Nogo-A. Scale bar: D, H: 100 µm, O: 10
µm.
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A

Nogo-A knockdown in vitro

B

Figure 7. Diminished Nogo-A protein levels following knockdown in
vitro and in vivo. (A) Plasmid transduced HEK293 cells show dose-dependent
decrease in Nogo-A protein levels. Blot shown is representative of a trend
observed in three separate replications. Numbers indicate the molar ratios of
shRNA:target. (B) When assessing cells from neocortical tissue sections labeled
for viral transduction via EGFP, AAV-EGFP-shNogo transduced neurons show a
reduction in Nogo-A immunoreactivity, when compared to AAV-EGFP control
virus. Data pooled from 50 cells/animal, 3 animals/group. * indicates p < 0.05,
two-tailed Student‘s t-test, error bars indicate SEM.
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Neuronal Nogo-A knockdown in vivo results in reduced apical
dendritic spine density and alterations in apical spine morphology.
After a 6 week survival period, EGFP-positive layer V pyramidal neurons
from rats transfected with AAV-EGFP had an average spine density of 10.7 ± 0.6
per 10 µm of dendrite length (see Fig. 2 for representative image). A 26%
reduction in neuronal dendritic spine density was detected in neurons
transduced with AAV-shNogo, with an average spine density of 7.9 ± 0.6 per 10
µm of dendrite length (p = 0.006, Fig. 8A).
Neurons from animals transduced with AAV-shNogo exhibited a
significant decrease in the proportion of thin-type spines (0.8 ± 0.2; p = 0.03) as
compared to neurons transduced with the control virus AAV-EGFP (1.7 ± 0.4;
Fig. 8B). A decrease in mushroom-shaped spines was also observed in adult
neocortical pyramidal neurons following loss of Nogo-A (6.2 ± 0.5 per 10 µm of
dendrite length for AAV-EGFP and 4.2 ± 0.5 for AAV-shNogo, p = 0.01, Fig. 8C).
Densities of filopodia protrusions (1.0 ± 0.2 per 10 µm of dendrite length for
AAV-EGFP and 1.1 ± 0.1, p = 0.62, data not shown), stubby (2.1 ± 0.1 per 10 µm
of dendrite length for AAV-EGFP and 2.6 ± 0.3 for AAV-shNogo, p = 0.14, data
not shown) and bifurcated spines (0.5 ± 0.2 per 10 µm of dendrite length for
AAV-EGFP and 0.3 ± 0.1 for AAV-shNogo, p = 0.22, data not shown) were
similar between groups.
Spine length (0.59 ± 0.03 µm for AAV-EGFP and 0.62 ± 0.03 µm for AAVshNogo, p = 0.43) and maximal spine head width (0.89 ± 0.05 µm for AAV-EGFP
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and 1.00 ± 0.10 µm for AAV-shNogo, p = 0.29) were measured, with no
significant differences observed between groups (data not shown). When
measurements were sorted by bins of 0.4 microns, a decrease in the number of
very long protrusions was observed in the Nogo-A knockdown group (longer than
1.2 µm, p = 0.002, Fig. 9A). Similarly, when spine width was binned, a slight
decrease in the number of wide protrusions was observed (width between 0.60.849, p = 0.047, Fig. 9B). Together, these results suggest that postnatal Nogo-A
gene knockdown influences apical spine dynamics in layer V neocortical
pyramidal neurons.

Reduced levels of postnatal, neuronal Nogo-A did not alter basilar
spine density or morphology.
As seen in Figure 10, basilar spine density was unchanged following NogoA knockdown (9.1 ± 1.2 spines per 10 µm dendrite length for AAV-EGFP and 7.8
± 0.7 for AAV-shNogo, p = 0.38, Fig. 10). Similarly, filopodia protrusions (1.4 ±
0.5 per 10 µm dendrite length for AAV-EGFP and 1.1 ± 0.3 for AAV-shNogo, p =
0.64, data not shown), mushroom (4.3 ± 0.5 per 10 µm dendrite length for AAVEGFP and 3.7 ± 0.5 for AAV-shNogo, p = 0.40, Fig. 10), stubby (2.3 ± 0.4 per 10
µm dendrite length for AAV-EGFP and 1.9 ± 0.3 for AAV-shNogo, p = 0.47, Fig.
10), thin (1.8 ± 0.2 per 10 µm dendrite length for AAV-EGFP and 1.4 ± 0.1 for
AAV-shNogo, p = 0.14, data not shown), or bifurcated spine morphology (0.7 ±
0.1 per 10 µm dendrite length for AAV-EGFP and 0.6 ± 0.1 for AAV-shNogo, p =
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0.71, data not shown) were not altered by the loss of Nogo-A in postnatal
development.
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A

B

C

Figure 8. Apical sensorimotor cortex spine density and morphology
following postnatal loss of Nogo-A. (A) Spine density was substantially
decreased in response to Nogo-A knockdown. (B) A decrease in mushroom- and
(C) thin-type spines was also observed. * indicates p < 0.05 via two-tailed
Student‘s t-test, n = 6 and 10 from EGFP and shNogo groups, error bars indicate
SEM.
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B

Figure 9. Apical sensorimotor cortex morphology following postnatal
loss of Nogo-Decreases in the density of very long spines (A) and wide spines
(B) were observed following postnatal loss of Nogo-A. * indicates p < 0.05 via
two-tailed Student‘s t-test, n = 6 and 10 from EGFP and shNogo groups, error
bars indicate SEM.
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A

B

C

Figure 10. Basilar sensorimotor cortex spine density and morphology
following postnatal loss of Nogo-A. (A) No substantial differences were
observed in spine density or spine morphology (B, C). Data pooled from 6
animals per group, Error bars indicate SEM.
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DISCUSSION
The results of this study indicate that postnatal suppression of Nogo-A by
AAV-delivered shRNA leads to a 26% reduction in spine density in apical
dendrites of pyramidal neurons in layer V of the sensorimotor neocortex.
Furthermore, morphological analysis of these transduced neurons showed a 52%
and 32% significant decrease of in mushroom and thin spines, respectively
suggesting a shift in spine morphology in the apical dendrites of neurons with
decreased amounts of Nogo-A. Postnatal Nogo-A knockdown also altered
morphology so there were 37% fewer protrusions with very long necks compared
to control group, and 22% fewer protrusions of moderately-wide diameter. No
changes were observed in basilar spine density or morphology between groups.
Nogo-A was initially isolated from CNS myelin and identified as a highly
potent inhibitor of neurite outgrowth (Caroni and Schwab, 1988). Over the past
two decades, numerous studies of anti-Nogo-A antibody infusion in animal
models of spinal cord injury and stroke have shown that this treatment results in
functional recovery, axonal regeneration, and neuronal plasticity (Gonzenbach
and Schwab, 2008). In particular, contralesional layer V neurons of the forelimb
sensorimotor cortex displayed increased axonal sprouting (Seymour et al., 2005),
dendritic complexity, and spine density (Papadopoulos et al., 2006) following
stroke and anti-Nogo-A immunotherapy in adult rats. However, after knockdown
in neonatal rats, our results of decreased spine density and altered spine
morphology support the hypothesis that an additional function of Nogo-A may be
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to promote spine development. When considering the present result of a decrease
in spine density seen after Nogo-A knockdown as compared to our previous
result of an increase in spine density after stroke and immunotherapy, several
explanations are possible. First, the age of the animals was different, and
decreasing the levels of Nogo-A protein in developing neurons could have led to a
different result than administering the anti-Nogo-A therapy in the adult animal.
Second, the axonal sprouting observed after anti-Nogo-A immunotherapy may
have led to a retrograde activity- or trophic-induced increase in spine formation
in the adult animals. Third, mechanistic differences between an antibodymediated therapy to neutralize global Nogo-A and direct loss of the protein in
neurons through RNAi cannot be ruled out; anti-Nogo-A shRNA affected
neuronal development over eight weeks‘ time, where the antibody was
administered to an established nervous system for only two weeks. Furthermore,
the knockdown approach eliminated surface and ER-localized Nogo-A, but the
antibody only affected molecules at the plasma membrane.
The changes in spine morphology seen in the apical tree are representative
of a deeper change in neuron functioning. Spine morphology is known to change
after LTP in hippocampal and cortical neurons, producing larger spine heads,
and shorter and wider spine necks in an actin-dependent manner (Fifkova, 1985;
Monfils and Teskey, 2004; Kopec et al., 2006). The decrease in both of these
measures seen after knockdown may indicate alterations in the formation of LTP
in neurons lacking postnatal Nogo-A. Furthermore, we also observed changes in
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apical spines when morphology was assessed by manually assigning spines to
different categories (Fig. 2, Chapter 2). This method is limited by the continuum
that exists between forms (Arellano et al., 2007a), but it does suggest alterations
in the distributed form of computing that spines perform (Yuste, 2010). Also,
mushroom spines have been shown to be more stable, so the loss of mushroom
spines observed here in response to neuronal Nogo-A knockdown may indicate
an increase in spine turnover (Parnass et al., 2000).
A clear future direction for this work would be to examine the possibility of
off-target effects. As an shRNA sequence, shNogo can avoid activating interferon
pathways as siRNA duplexes that lack the 2 NT overhang would. Also, because
our sequence is only 19-nt long, it is able to avoid PKR off-target pathways which
are triggered by RNA sequences over 33 NT long. Previous work in our lab has
shown that spine density is not affected by exogenous short hairpin delivered by
AAV2/8 over a 7 week postnatal time period. This hairpin was directed against
firefly Luciferase and the plasmid also encoded for the fluorophore ZS-green
(Pradhan et al., 2010). This hairpin would not control for shNogo856 off-target
effects because these effects are specific to the sequence used for RNAi. A BLAST
search shows that shNogo856 only targets Nogo-A in Rattus norvegicus to a
significant degree of sequence matches (E value < 0.1). Another recently
developed algorithm has indicated that Foocen-m1, a poorly-characterized
member of the reticulon family, may be susceptible to regulation via the
shNogo856 sequence, though this protein is the only match besides Nogo-A

55
(Ryan et al., 2008). Future studies would benefit from use of a second vector to
knock down Nogo-A, directed against a different sequence, to rule out the
possibility of off-target effects. Further insight into this possibility may be gained
from an examination of interferon gene expression.
The lack of response in the basilar spines to the loss of neuronal Nogo-A
was unexpected, but may be due to subtle differences in wiring between the
different regions on the dendritic tree. For example, the proximal apical and
basilar arbors are innvervated by layer 5 neurons from the ipsilateral cortex. The
basilar arbor receives additional inputs form layer 3 neurons from the
contralateral cortex, and thus serves to also integrate regions from the different
cortices (Deuchars et al., 1994; Lubke et al., 1996; Thomson and Bannister,
1998). Hippocampal slice cultures treated with anti-Nogo-A antibody display
similar differences in responsiveness between different regions of the
hippocampal dendritic arbor. Specifically, pyramidal neurons of the CA1 that had
been treated with the anti-Nogo-A antibody 11C7 showed increase in stubby-type
spines of the distal apical arbor, but no change to other dendritic regions.
Pyramidal neurons of the CA3 receiving the same treatment saw no change to
dendritic complexity in their proximal apical tree, but a statistically significant
increase in complexity of the distal apical tuft (Zagrebelsky et al., 2010). While
these slice cultures were obtained from P5 mouse pups and maintained for at
least three weeks in vitro, they can not translate directly into this study on this
nine-week postnatal developmental window in vivo. Nevertheless, the results
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from this study support the general hypothesis that Nogo-A signaling can
maintain synaptic and dendritic structures.
Several mechanisms may underlie Nogo-A‘s role in plasticity and
development, including the actions of intracellular Nogo-A, and interaction with
a Nogo-66 receptor (NgR1) or integrins (Voeltz et al., 2006). NgR1 has been
shown to mediate changes in neuronal plasticity (McGee et al., 2005), including
spine morphology, synaptic function (Lee et al., 2008; Raiker et al., 2010), and
length of neuronal stem cell neurites (Wang and Zhu, 2008). Integrins can
interact with the amino-terminal of Nogo-A (Hu and Strittmatter, 2008), and
have also been implicated in dendritic spine plasticity (Shi and Ethell, 2006;
Webb et al., 2007). Nogo proteins have been implicated in migration of
neocortical interneurons during embryonic development in vivo (Mingorance-Le
Meur et al., 2007). Loss of these proteins in cultured cortical neurons increases
both the rate of neurite polarization and the magnitude of neurite branching,
potentially through intracellular mechanisms (Mingorance-Le Meur et al., 2007).
Indeed, intracellular Nogo-A has been reported to induce topological changes in
another membranous structure, the ER (Voeltz et al., 2006; Kiseleva et al., 2007).
While the molecular mechanism of spine loss observed here has yet to be
uncovered, our results suggest that endogenous levels of Nogo-A expression in
postnatal development are necessary for the formation and maintenance of spine
density and morphology.

CHAPTER FOUR
POSTNATAL KNOCKDOWN OF NEURONAL NOGO-A LEADS TO A
DECREASE IN MESSAGE LEVELS OF GENES IMPORTANT FOR
SYNAPTIC PLASTICITY
ABSTRACT
Nogo-A protein is an important regulator of neurite outgrowth, and is a
recognized inhibitor of functional recovery and anatomical plasticity after CNS
injury. This negative role Nogo-A plays in the injured CNS has led researchers to
investigate beneficial roles that may have aided in the evolutionary conservation
of this protein. To examine the roles of this protein at the synapse of the intact
CNS, we used RNAi directed against Nogo-A and delivered it to the developing
rat sensorimotor cortex via AAV2/8, a neurotropic vector. We examined regions
of transduced cortex via qRT-PCR for message levels of molecules important for
synaptic plasticity, including Neuroligin-1, NMDA receptor subunits NR2A and
NR2B, and PSD-95. We found that mRNA of Neuroligin-1 and NR2B were
substantially reduced, with no changes to PSD-95 and NR2A expression. These
results suggest that neuronal Nogo-A may regulate synaptic plasticity by means
of controlling the molecular composition at synapses. This finding represents a
novel role for Nogo-A in neurons of the uninjured CNS.
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INTRODUCTION
The potent neurite outgrowth inhibitory protein Nogo-A is found in
myelin sheaths and in some subsets of neurons (Huber et al., 2002; Wang et al.,
2002b; Liu et al., 2003; Cheatwood et al., 2008). Studies of oligodendrocyteassociated Nogo-A have shown the protein causes axonal growth cone collapse, at
least in part through the downstream signaling of NgR1, which is found in
neurons (Chivatakarn et al., 2007; Raiker et al., 2010). Antibody therapies
directed against Nogo-A have shown promise in preclinical and clinical stage I
trials for the treatment of spinal cord injury (Freund et al., 2006; Zorner and
Schwab, 2010). This same treatment has also led to functional recovery in rat
models of stroke (Wiessner et al., 2003; Tsai et al., 2010), even if the treatment is
not administered until two months after injury (Tsai et al., 2010). An
understanding of how Nogo-A regulates plasticity at the synapse may aid in the
discovery of new therapeutic avenues for several neurological conditions.
To determine the role of Nogo-A at the synapse, we examined the
expression pattern of molecules that are elements of the functional excitatory
synapse following postnatal knockdown of neuronal Nogo-A. We chose to
examine rat neuron development because this is where cortical neuron
synaptogenesis occurs, and neuronal Nogo-A expression peaks at this time
(Huber et al., 2002; Hunt et al., 2003; Buss et al., 2005; Mingorance-Le Meur et
al., 2007). The resulting molecular phenotype may give insight into synaptic
plasticity of neurons that lack Nogo-A. We examined the molecules post-synaptic
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density 95 (PSD-95), the NR2A and NR2B subunits of the NMDA receptor, and
neuroligin 1. PSD-95 is an intracellular postsynaptic anchoring molecule
localized to active synapses that serves to stabilize many key elements of synaptic
transmission, including glutamate receptors and the actin cytoskeleton (Blanpied
et al., 2008; Chen et al., 2008). A shift in the predominance of NMDA receptor
subunits NR2A and NR2B is an indicator of a change in the threshold of usedependent plasticity (Tang et al., 2001; Liu et al., 2004; Fu et al., 2005; Yashiro
and Philpot, 2008; Corson et al., 2009). Neuroligin-1 is an intercellular
anchoring molecule, one of the final molecules to be delivered to the site of
synapse assembly (Nam and Chen, 2005; Gerrow et al., 2006; Barrow et al.,
2009). These molecules are all mediators of excitatory signaling and known to
regulate synaptic plasticity, including long-term potentiation. We also examined
levels of the Nogo-A splice variant Nogo-B and Cofilin, a known downstream
target of Nogo-A signaling. This allowed us to compare our model to others that
have demonstrated changes in these molecules in Nogo-A knockout mice (Dimou
et al., 2006; Montani et al., 2009).
In rats with neuronal Nogo-A knockdown, we saw a decrease with respect
to control group in the expression of NR2A, NR2B and Neuroligin-1, with no
substantial differences to PSD-95, Nogo-B or Cofilin.
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METHODS
Quantitative RT-PCR (qRT-PCR)
Isolation of mRNA
P3 rats were injected with AAV as described in Chapter Three. At P65, rats
were decapitated and their brains were rapidly removed, frozen in isopentane,
and stored at -80˚C until further processing. Approximately 30 milligrams of
tissue from the sensorimotor cortex was quickly dissected over ice and
homogenized in ice-cold TRIzol (Invitrogen). During the course of
microdissection, the brain was frequently rotated between the dissection plate
and dry ice to prevent the tissue from thawing to room temperature. Regions
were chosen based on previous studies of viral spread. Total RNA was extracted
per (Chomczynski and Sacchi, 2006)). Genomic DNA was degraded and
eliminated using TURBO DNA-free (Ambion) according to manufacturer‘s
instructions. Five µg of RNA was reverse-transcribed to synthesize first-strand
complementary DNA (cDNA) using Superscript II (Invitrogen), and the resulting
cDNA was diluted to 100 µL. ―No template‖ controls were used to detect any
potential contamination at the reverse-transcription step, and also with every set
of PCR reactions.
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PCR reaction
For each PCR reaction tube, 1 µL of cDNA templates (diluted as described
above) was added to a solution of primer pairs (Table 2) and SYBR-green
Supermix (Bio-Rad), with the exception of EGFP cDNA, which was amplified
using EGFP primers (QT01171611, QIAGEN) and QuantiTect SYBR Green PCR
Master Mix (QIAGEN). SYBR-green fluorescence was detected at the end of
every extension step (Table 2). All real-time PCR reactions were performed in
triplicate, with the average cycle threshold (CT) value used to quantify cDNA.
Relative cDNA amounts were calculated according to (Pfaffl, 2001), with GAPDH
as the reference gene. Absolute EGFP expression was used to identify samples
with high transduction, and the animals in the upper 50th percentile of EGFP
expression were used in analysis. Six animals in the EGFP group and five
animals in the shNogo group were used in the final analysis.

Primers
For each set of primer pairs, end products were run on gels to verify
product base pair (bp) size until the primer set was optimized (Fig. 13), at which
point the thermal melting curve analysis was used to verify specificity.
Amplification efficiency of all target and reference genes was calculated from the
CT values of serially diluted templates. Serial dilutions of cDNA, amplified using
all primer sets, replicated in a linear fashion (in all cases, r2 > 0.99).
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Statistical analyses
Due to the inherent variability in the qRT-PCR technique, mathematical
outliers, as determined by Tukey fences, were excluded from analysis. Prism 4
for Windows (GraphPad Software, Inc.) was used to analyze all data via the F-test
to compare variances. In cases where variances between groups were not
significantly different, data was analyzed by the two-tailed Student‘s t-test. If
variances between groups were found to be different, data was then analyzed via
two-tailed Student‘s t-test with Welch‘s correction. In all cases, p < 0.05 was
regarded as statistically significant.

GGAGTTGCTGT
TGAAGTC
TCTTAAGGGGT
GCACTCTCG
TGATGACGATC
ACATTACCG

GATAGTTAGTG
ATCCCACTG
AGGCAATGAAT
CTGCCCC
CCCACATCAACA
CTGCAAAC
GCTTCTAGGGT
GTCCGTGTT

AACCTGCCAA
GTATGATG
GGCGGCTCTG
TTCTTCTGTA
AAGGAGATAT
TCGGGACAGT
ATACCGGCAG
AACTCCACAC
GGATCTACCA
GTCTAACATG
TAGTGCCTCAC
CTCAGGAGC
GGCTCAGTGG
TTGTTGACCT
GACAACCAAG
AAATACCGCT

GAPDH
Cofilin
Neuroligin
NMDA
NR2A
NMDA
NR2B
Nogo-A

Nogo-B

PSD-95

CTCTTGCTGTCC
TCCAGACC

Reverse primer

Forward Primer

Gene

parameters for candidate genes.
120

376

364

563

441

122

390

119

Amplicon
size (bp)

1:00

1:00

1:00

1:00

0:15

1:00

1:00

0:10

Denature
94˚C (s)

1:00
(60˚)

1:00
(60˚)

1:00
(60˚)

1:00
(58˚)

0:20
(63˚)

1:00
(60˚)

1:00
(60˚)

0:30
(56˚)

Anneal
(s)

1:00

1:00

1:00

2:00

0:10

1:00

1:00

0:30

Extend
72˚C (s)

Cycling parameters
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Table 2. Primer sequences, anticipated product size, and cycling
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Figure 11. Representative gel banding patterns for primer sets used in
qRT-PCR experiments. Indicated PCR products from microdissected tissue
were run on agarose gels. DNA ladder (bp) indicated on the left. Duplicates and
triplicates in the bottom panel represent 10- and 100-fold dilutions of the original
amount of cDNA, respectively.
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RESULTS
AAV-shNogo leads to reduced levels of Nogo-A, with no changes to
Nogo-B or Cofilin expression.
We first sought to validate the selected method of tissue sampling, which
involved microdissection by hand of neocortical regions transduced with AAV.
Because this method was known to contain both transduced and untransduced
neurons, we chose to examine only the samples with the highest amount of AAV
transduction, as assessed by EGFP expression. Using this method, we analyzed
the relative amount of the shRNA target, Nogo-A. Relative expression was
calculated by the differences in CT values between the gene of interest and the
GAPDH housekeeping gene, which is unaffected by Nogo-A knockdown (p =
0.34, Fig. 12). Relative message levels of Nogo-A were significantly reduced in
AAV-shNogo samples (0.12 ± 0.05) with respect to the AAV-EGFP control group
(1.00 ± 0.33, p = 0.047, Fig. 13A).
The next objective was to compare our neuronal Nogo-A knockdown rat
model to the Nogo-A knockout mouse paradigm, which displayed two-fold
increase in Nogo-B protein (Dimou et al., 2006; Montani et al., 2009). Relative
quantities of Nogo-B mRNA remained unchanged between groups (0.45 ± 0.18
for AAV-shNogo and 1.00 ± 0.30 for AAV-EGFP control, p = 0.21), and Cofilin
expression was similar between groups (0.56 ± 0.17 for AAV-shNogo and 1.0 ±
0.14 for AAV-EGFP, p = 0.08, Fig. 13). Therefore, our knockout model used here
has the advantage of lacking at least the Nogo-B compensation issue.
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Postnatal loss of Nogo-A influences expression of genes important for
synaptic plasticity.
Relative mRNA levels of the post-synaptic scaffold PSD-95 (1.00 ± 0.25 for
AAV-EGFP and 1.23 ± 0.39 for AAV-shNogo, p = 0.62, Fig. 14) and the NMDA
receptor subunit NR2A (1.00 ± 0.45 for AAV-EGFP and 0.18 ± 0.04 for AAVshNogo, p = 0.14) displayed no substantial differences between groups. There
were significant decreases to message levels of Neuroligin-1 (1.00 ± 0.10 for AAVEGFP and 0.40 ± 0.11 for AAV-shNogo, p = 0.003) and NR2B (1.00 ± 0.18 for
AAV-EGFP and 0.14 ± 0.06 for AAV-shNogo, p = 0.005) following knockdown of
postnatal, neuronal Nogo-A (Fig. 14). The ratio of NR2A/NR2B was similar
between groups (1.00 ± 0.47 for AAV-EGFP and 4.79 ± 2.41 for AAV-shNogo, p =
0.22).
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Figure 12. GAPDH expression was similar between groups, as
determined by two-tailed Student‘s t-test with Welch‘s correction. This holds
true even if the two mathematical outliers in the shNogo group were to be
excluded. n = 6 for EGFP and n = 5 animals for shNogo, error bars indicate SEM
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Figure 13. Relative expression levels of Nogo-A, Nogo-B, and Cofilin
mRNA in samples with highest AAV transduction. (A) Levels of Nogo-A
were decreased in response to AAV-shNogo, while (B) Nogo-B expression was
unchanged. (C) Cofilin mRNA was not appreciably different in response to loss
of Nogo-A. Levels are relative to each sample‘s GAPDH CT value, and results for
each candidate gene are normalized to the average value of the AAV-EGFP
control group. * indicates p < 0.05 via two-tailed Student‘s t-test, n = 6 for EGFP
and n = 5 animals for shNogo, error bars indicate SEM.
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Figure 14. Relative expression levels of selected postsynaptic
molecules’ mRNA in samples with highest AAV transduction. (A)
While the levels of PSD-95 and (B) NR2A were unchanged in response to loss of
Nogo-A, there was a reduction in the amount of (C) Neuroligin-1 and (D) NR2B
message. Levels are relative to each sample‘s GAPDH CT value, and results for
each candidate gene are normalized to the average value of the AAV-EGFP
control group. * indicates p < 0.05 via two-tailed Student‘s t-test, n = 6 for EGFP
and n = 5 animals for shNogo group, error bars indicate SEM.
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DISCUSSION
The results from this study show that postnatal knockdown of Nogo-A
results in an 88% reduction in Nogo-A mRNA, 60% reduction Neuroligin-1, and
an 86% decrease in the NMDA receptor subunit NR2B in the sensorimotor cortex
when compared to the AAV-EGFP control group. No change was detected in the
message levels of Nogo-B, Cofilin, and PSD-95 compared to controls. The NMDA
receptor subunit NR2A did not show a statistically significant reduction in
mRNA, but there was an 82% decrease when compared to the control group.
The excitatory synaptic adhesion molecule Neuroligin-1 was decreased in
rats with neuronal Nogo-A knockdown. Neuroligin-1 and -2 are found exclusively
at excitatory and inhibitory synapses, respectively (Graf et al., 2004; Levinson
and El-Husseini, 2005; Chubykin et al., 2007). Using a postnatal mouse
overexpression paradigm of Nogo-A in cerebellar Purkinje neurons, Aloy et al.
(2006) saw a decrease of Neuroligin-2 as well as several other indications of
synaptic disassembly. Interestingly, our model of decreased Nogo-A protein
levels resulted in a decrease in Neuroligin-1, although we did not examine
Neuroligin-2 and they did not examine Neuroligin-1. However, the fact that
overexpression and knockdown paradigms led to similar changes in Neuroligin
expression—and synaptic destabilization—may be due to potential model-specific
effects, or the difference between inhibitory and excitatory synapse regulation.
We found that Nogo-A knockdown led to a significant decrease in the
message levels of the glutamatergic NMDA receptor subunits NR2B, but only a
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trend toward decreased NR2A. NMDA receptors are key mediators of synaptic
plasticity and an established means of coincidence detection (see Chapter Two).
NR2-A and -B subunit expression represents a kind of reciprocal control of the
threshold for modifying synaptic strength. Neuronal activity generally facilitates
transcription and surface delivery of NR2A, but it represses transcription of
NR2B and facilitates NR2B degradation (Fu et al., 2005; Yashiro and Philpot,
2008; Corson et al., 2009).
In the first weeks of postnatal development, NR2B subunits predominate
over NR2A. This pattern is shifted in the young adult, where there are more
NR2A subunits than NR2B (Tang et al., 2001; Liu et al., 2004; Giza et al., 2006).
We did not see a shift in the ratio between NR2A/NR2B between the young
adults in each treatment group. Instead, both subunits decrease to a similar
degree in the AAV-shNogo group—82% decrease in NR2A and 86% decrease in
NR2B—perhaps suggesting a broader decline in the expression of this receptor
entirely. The growth of spines into a mushroom morphology requires the
presence of NMDA receptors (Matsuzaki et al., 2004), and the decrease in NMDA
receptor subunits seen here in response to loss of Nogo-A may be linked to our
previous finding of fewer mushroom spines in animals after postnatal Nogo-A
knockdown (Chapter three). The result may also relate to other laboratories‘
observations of altered LTP in Nogo-A knockout mouse hippocampal neurons,
since NMDA receptors are known mediators of the coincidence detection
required for LTP (Delekate et al., 2011).
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It is important to note that NMDA receptors are found at sites other than
synapses. In the rat hippocampus, approximately 36% of the total dendritic
NMDA receptor pool can be extrasynaptic (Harris and Pettit, 2007).
Furthermore, signaling through this second pool of NMDA receptors appears to
have a different functional consequence than signaling at synapses. Signaling
through nonsynaptic NMDA receptors can lead to neurotoxicity (Hardingham
and Bading, 2010). Potential mechanisms involved in the differential signaling
between synaptic and nonsynaptic NMDA receptors may include the different
types of signaling complexes available at these sites, and the nature of activation
such as transient spikes at the synapse compared to chronic low-level signaling as
a result of increased extracellular glutamate at nonsynaptic NMDA receptors
(Hardingham and Bading, 2010).
It is possible that the decrease in NMDA receptor subunits seen here may
reflect a loss of receptors at extrasynaptic sites. This would be in keeping with a
pro-apoptotic role that has been proposed for Nogo proteins (Chen et al., 2006;
Kuang et al., 2006; Xu et al., 2006; Teng and Tang, 2008). However, the
synaptic pool of NMDA receptors is most likely affected by postnatal neuronal
knockdown, given the estimated proportion of extrasynaptic NMDA receptors
comprising about a third of all NMDA receptors (Harris and Pettit, 2007), and
decreases upwards of 80% in NMDA receptor subunits in our samples (Figure
14).
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We saw no significant changes to Cofilin or Nogo-B expression between
rats with postnatal, neuronal Nogo-A knockdown and the control group. This
result is in contrast to Nogo-A knockout mice, which displayed alterations in
Cofilin signaling and a compensatory increase in Nogo-B expression (Dimou et
al., 2006; Montani et al., 2009). This difference in results could be due to the
way knockout mice are generated, i.e., all Nogo-A in all cell types would be
absent, whereas our only target using the viral mediated knockdown approach is
neuronal Nogo-A. Furthermore, while Nogo-B expression has not been linked to
altered dendritic structure (Zagrebelsky et al., 2010), the lack of Nogo-B
compensation might confer a slight advantage to our AAV-mediated knockdown
model used here.
In our study, the relative mRNA expression of the excitatory postsynaptic
scaffolding molecule PSD-95 remained unchanged. PSD-95 expression has been
linked to the density and size of spines (El-Husseini et al., 2000; Chang et al.,
2009), although synaptic plasticity has also been observed with no change to
overall protein density in PSD-95 (Blanpied et al., 2008). One possible
interpretation of our data is that Nogo-A knockdown may lead to an increase in
PSD-95 per spine, given the decrease in spines seen in the apical arbor (Chapter
three). It is also possible that the lack of change is influenced by untransduced
neurons, or the continued expression of Nogo-B which can signal through NgR1
through its Nogo-66 loop (see Fig. 1). A third possible interpretation is that
regulation of the PSD-95 scaffold occurs in this system by another means. The
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protein has a half life of approximately 100 minutes at the postsynaptic density
(Gray et al., 2006), so it is reasonable to assume that mRNA levels may serve as a
sensitive indicator of protein levels. However, PSD-95 activity is known to be
regulated by extrasynaptic localization and phosphorylation in addition to
protein expression, and it is possible that these methods of post-translational
regulation are simply more fundamental than translational means (Bence et al.,
2005; Morita et al., 2006; Barrow et al., 2009). A study of PSD-95 protein levels
and localization using immunohistochemistry and high-resolution imaging might
clarify this matter.
In conclusion, we found that loss of postnatal Nogo-A in neurons of the
sensorimotor cortex is associated with a decrease in several molecules key for
glutamatergic transmission and plasticity: Neuroligin-1 and the NMDA receptor
subunits NR2A and NR2B. The lack of change to PSD-95 indicates that some
elements are still intact. We propose a role for neuronal Nogo-A in the
distribution of molecules important for excitatory synaptic function over the
postnatal window of development. Our findings give further insight into the roles
of this protein in the intact CNS, although additional study is needed to
determine the molecular mechanisms underlying this finding.

CHAPTER FIVE
POSTNATAL KNOCKDOWN OF NEURONAL NOGO-A LEADS TO A
DECREASE IN THE APICAL COUNT OF AN EXCITATORY
PRESYNAPTIC MARKER, VGLUT1, IN THE
ADULT SENSORIMOTOR CORTEX
ABSTRACT
Anti-Nogo-A immunotherapy has shown great promise in promoting
functional recovery and anatomical plasticity in rodent and primate models of
CNS injury. Studies of Nogo-A function in the uninjured rodent have suggested a
role in neuronal development. To study the role of Nogo-A in the intact
neocortex, we used vesicular glutamate transporter 1 (vGlut1) as a presynaptic
marker for potential excitatory synapses. We found that knocking down Nogo-A
in postnatal pyramidal neurons of the sensorimotor cortex led to a decrease in
the number of vGlut1 puncta identifying a potential presynaptic partner, in
opposition to the apical dendritic shaft. Though we found no changes to vGlut1
density in the basilar arbor, the decreased vGlut1 in the apical arbor likely
represents a loss of potential synapses that may have a strong influence on direct
current injected into the dendrite.
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INTRODUCTION
Our previous work has shown that loss of neuronal Nogo-A leads to a
decrease in the density of apical dendritic spines in neocortical pyramidal
neurons (Chapter 3). We also found that this treatment leads to a decrease in the
expression of several molecules key for synaptic structure and plasticity (Chapter
4). Nogo-A‘s putative roles in synaptic plasticity are thought to include the
regulation of axonal outgrowth and stabilization, as well as presynaptic release of
dopamine, although this latter function is less well-studied (Xiong et al., 2008;
Schwab, 2010; Zagrebelsky et al., 2010). The question remains whether Nogo-A
in neurons can affect presynaptic machinery as it does within oligodendrocytes.
Excitatory dendritic synapses are present at all stages of brain
development and often have a strong influence on dendritic currents. While
dendrite shafts are more often reserved for inhibitory synapses, estimates of
glutamatergic shaft synapses can range from 4-10% of a neuron‘s total excitatory
synapses in adulthood (Gray, 1959; Boyer et al., 1998). In early postnatal
development, this number can increase to as much as 50% (Boyer et al., 1998).
In our attempt to study the effects of neuronal Nogo-A on properties of the
excitatory synapse, we used deconvolution microscopy of fluorescently-tagged,
potential presynaptic sites in opposition to EGFP-filled dendrites. Deconvolution
microscopy offers a similar resolution capacity as laser confocal microscopy but
has the advantage of very little photobleaching associated with high-resolution
images, allowing improved quantification of fluorescence. Identifying
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presynaptic markers opposing spines and dendrites is facilitated by the
resolution limit of deconvolution microscopy. The width of the synaptic cleft is
approximately 20 nm, maintained through the collective action of many pairs of
transsynaptic anchoring molecules. While fluorescently labeled proteins on
either side of this 20 nm cleft are not truly in the same compartment as one
another, they will appear at least partly colocalized when imaged by
deconvolution microscopy, since the technique has a resolution limit of <200 nm.
The color shift (yellow puncta in Figs. 17, 18) that results actually aids in
colocalization analysis.
We chose to use vesicular glutamate transporter 1 (vGlut1) as a marker for
potential excitatory synapses because these synapses by definition use glutamate
as a neurotransmitter. We found that knocking down Nogo-A in postnatal
neurons leads to a decrease in the apical density of potential presynaptic partner,
vGlut1, on dendritic shafts. This likely represents a loss of potential synapses
that may have a strong influence on direct current injected into the dendrite.
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METHODS
Immunohistochemical staining
Rats were injected with AAV and perfused as described in Chapter Three.
Brains were cryoprotected for 72 hours in 30% sucrose solution, cut at 40 µm
thickness on a cryostat, and stored in PBS with azide for no more than three
weeks prior to staining. Tissue sections were assessed for EGFP expression on
uncoated slides at low magnification, and six optimal sections were chosen for
each rat sample (Fig. 15). Selected free-floating tissue sections were
permeabilized with 30 mM PIPES buffer-0.1% saponin for six hours at room
temperature before postfixing in 4% PFA for five minutes. Sections underwent
four washes in buffer (TBS-0.3% Triton-X-100) for five minutes each. Blocking
was performed for 90 minutes at room temperature in buffer containing 10%
Normal Donkey Serum (NDS).
Primary polyclonal antibody directed against guinea-pig vesicular
glutamate transporter 1 (vGlut1), at 1:4000 dilution (Millipore AB5905) in buffer
containing 5% NDS was added for three nights at 4˚C, with agitation. Sections
were rinsed in buffer for three 20 minute washes and one 40 minute wash.
DyLight649 anti-guinea pig secondary, 1:400 dilution (Jackson
ImmunoResearch 706-495-148) in buffer containing 5% NDS was allowed to
incubate overnight at 4˚C. Sections were rinsed for five 20 minute washes in
buffer, one 60 minute wash in buffer, and a final wash for 5 mins in 0.1M
phosphate buffer before mounting to gel-coated slides. Slides were dried,
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coverslipped in Fluoromount-G mounting medium, and stored at 4˚C for at least
one day prior to imaging (Fig. 15). For each sample, a ―no primary‖ control was
utilized to assess background fluorescence as well as nonspecific staining from
the secondary antibody. Sections from different rats were stained and imaged in
parallel, and the experimenter was blinded with regard to treatment groups
throughout all staining, imaging, and analysis procedures.

Synaptic protein imaging via deconvolution microscopy
EGFP-filled excitatory pyramidal neurons from the sensorimotor forelimb
cortex region were identified by morphology. A total of six rats were examined
per treatment group. For each rat, z-stacks of dendritic segments from five
different neurons were imaged in each the basilar and proximal apical arbors.
Apical and basilar arbors were differentiated by morphology, where apical arbors
are characterized by a thick primary dendrite extending from the pial-most
region of the neuron cell body towards the pial surface, and basilar dendrites
comprise all other branches originating on the cell soma. Dendritic segments
analyzed were required to be at least 10 µm in length, and their dendritic
protrusions had to be completely encapsulated within the z-stack.
Z-stacks of images were taken on an inverted microscope (Olympus) using
a 100x oil-immersion objective. Focal planes were spaced 0.3 µm apart on the zaxis, at 1024x1024 resolution, binning of 1x1. Image stacks were deconvoluted via
softWoRx Deltavision (Applied Precision) and analyzed for density of vGlut1-
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positive puncta colocalized with EGFP with ImageJ software (NIH). vGlut1+
puncta colocalized with EGFP-filled dendrites were counted and categorized
according to their placement on the dendritic shaft or spine, as identified by
morphology seen through the imaging stack (Fig. 15).

Statistical analyses
Prism 4 for Windows (GraphPad Software, Inc.) was used to analyze data
via the two-tailed Student‘s t-test. In all cases, p < 0.05 was regarded as
statistically significant.
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Figure 15. Methods used to stain and examine EGFP-filled dendrites in
thinly-sliced tissue.
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RESULTS
vGlut1 immunohistochemistry identifies potential presynaptic
terminals.
vGlut1 immunostaining patterns resembled previous published reports
(Alonso-Nanclares et al., 2004; Cubelos et al., 2005; Melone et al., 2005; Kubota
et al., 2007; Tabuchi et al., 2007), with punctuate arrangements seen throughout
neocortical grey matter, but absent from neuronal somas (Fig. 16A). This latter
effect was well demonstrated in the hippocampus, where the stratum pyramidale
was negative for vGlut1 immunoreactivity (Fig. 16B). The vGlut1+ puncta were
found at the distal tips of spines, where synapses are known to form (Harris et al.,
1992), in approximately 87% of spines analyzed (Figs. 17, 18). Furthermore, ―no
primary‖ controls expressed little to no signal, and the maximal light intensity
values were less than 5% of that seen in stained tissue sections. Given all this, the
vGlut1+ puncta serve as a reliable indicator for potential presynaptic terminals.

AAV-shNogo leads to reduced number of potential presynaptic
connections onto apical dendrites.
Loss of postnatal Nogo-A, in neurons, was associated with a decrease in
vGlut1+ puncta colocalizing onto dendrites (13.5 ± 1.3 colocalized puncta per 10
µm dendrite for AAV-EGFP and 9.1 ± 1.1 for AAV-shNogo, p = 0.03, Fig. 19A).
This change was due to a decrease in puncta at the dendritic shaft (2.5 ± 0.2
colocalized puncta per 10 µm dendrite for AAV-EGFP and 1.6 ± 0.2 for AAV-
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shNogo, p = 0.01, Fig. 19B), and not due to the aforementioned decrease in
dendritic spines because there were no significant changes seen in the density of
colocalization with dendritic spines (10.5 ± 1.5 colocalized puncta per 10 µm
dendrite for AAV-EGFP and 7.5 ± 0.9 for AAV-shNogo, p = 0.12, Fig. 19C).
Indeed, the percentage of spines that colocalized with vGlut1+ puncta was not
different between groups (86.5% ± 3.6 for AAV-EGFP and 83.2% ± 1.7 for AAVshNogo, p = 0.39, data not shown). This suggests a potential loss in the density
of presynaptic terminals situated on the apical dendritic shaft of animals with
decreased postnatal, neuronal Nogo-A expression.

Decreased postnatal levels of Nogo-A protein does not affect vGlut1+
colocalization with basilar dendrites.
Dendrites of the basilar arbor did not show a change in density of vGlut1+
colocalization in the total dendritic compartment (12.4 ± 1.9 colocalized puncta
per 10 µm dendrite in AAV-EGFP, 10.8 ± 1.2 for AAV-shNogo, p = 0.49, Fig.
20A), dendritic shafts (3.6 ± 0.6 colocalized puncta per 10 µm dendrite for AAVEGFP and 2.8 ± 0.4 for AAV-shNogo, p = 0.36, Fig. 20B), or dendritic spines (9.1
± 1.6 colocalized puncta per 10 µm dendrite in AAV-EGFP, 7.9 ± 1.0 for AAVshNogo, p = 0.53, Fig. 20C). As with the apical arbor, the percentage of spines
that colocalized with vGlut1+ puncta was not different between groups (89.6% ±
2.2 for AAV-EGFP and 89.3% ± 2.6 for AAV-shNogo, p = 0.93, data not shown).
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Thus, the concentration of potential presynaptic terminals is unchanged in
dendrites of the basilar arbor in response to Nogo-A knockdown.
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Figure 16. Representative vGlut1+ immunoreactivity. (A) Neocortical
layer V region with punctuate staining throughout the parenchyma, and
pyramidal cell soma profiles visible by their lack of staining. (B) Lowmagnification image of the hippocampus with staining absent from white matter
and stratum pyramidale (arrowheads). (C) Orthogonal view of stack taken on
confocal microscope with 1 µm thick optical slices showing antibody penetration
through the thickness of the tissue. Scale bars denote (A) 300 and (B, C) 50
micrometers.
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Figure 17. vGlut1+ puncta and EGFP colocalization. Deconvolved high
magnification z-slice image of (A) spines in green, (B) vGlut1+ puncta in red, and
(C) their colocalization in yellow. Yellow arrowheads indicate dendritic
colocalization; arrows indicate shaft synapse colocalization. Scale bars indicate 1
micrometer.
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Figure 18. vGlut1+ puncta and EGFP colocalization. Deconvolved high
magnification z-slice image of (A) spines in green, (B) vGlut1+ puncta in red, and
(C) their colocalization in yellow (yellow arrowheads). Though the postsynaptic
EGFP and presynaptic immunolabeled vGlut1 are present in separate cells, they
appear colocalized because of the resolution restrictions of deconvolution
microscopy. Scale bar indicates 1 micrometer.
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Figure 19. Colocalization of vGlut1 and EGFP-filled apical dendrites.
(A) Postnatal, neuronal Nogo-A knockdown leads to a decrease in vGlut1 in apical
dendrites of the sensorimotor cortex. (B) This change can be attributed to the
vGlut1+ puncta opposing the dendritic shaft compartment. (C)There was no
substantial change in the average number of colocalized puncta on the apical
dendritic spines of these neurons. Error bars indicate SEM, data pooled from 6
animals per group, * indicates p < 0.05, two-tailed Mann-Whitney test.
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Figure 20. Colocalization of vGlut1 and EGFP-filled basilar dendrites.
(A) Postnatal, neuronal Nogo-A knockdown does not affect colocalization in
basilar dendrites of the pyramidal cells of the neocortex. (B) No differences in
puncta density were distinguished on the dendrites of these neurons. (C) The
density of vGlut in opposition to dendritic spines in the basilar arbor was
unchanged following loss of Nogo-A in sensorimotor neurons. Data pooled from
6 animals per group, error bars indicate SEM.
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DISCUSSION
We found that loss of Nogo-A in a subset of developing neurons affected
the density of a potential presynaptic partner, vGlut1, in the apical compartment
of the dendritic arbor. This decreased density of vGlut1-immunoreactive puncta
was attributed to a 36% loss of potential synapses onto dendritic shafts, as
opposed to dendritic spines, since the percentage of apical spines with a potential
presynaptic partner was similar between groups. These results are consistent
with the hypothesis that neuronal Nogo-A regulates properties of the excitatory
synapse in the apical arbor of neocortical pyramidal neurons.
Our previous study of Nogo-A‘s effects on dendritic spines did not address
the possibility of a compensatory increase in excitatory synapses onto the
dendritic shaft (Mateos et al., 2007). Moreover, dendritic spines may contain
more than one synapse, and approximately 4-10% of neocortical spines have no
synaptic connections (Gray, 1959; Arellano et al., 2007b). Computational models
have shown inputs via shaft synapses, though they have less computational
potential than spine synapses, have been predicted by cable theory to inject more
direct current into the dendrite (Byrne, 2003). Shaft synapses have also been
shown to have a larger PSD area than spine synapses (Rusakov et al., 1998).
Dendritic shaft synapses are also less likely to have a perforated morphology than
spine synapses (Anderson and Martin, 2006).
Functionally, the decreased density in potential shaft synapses seen in
response to reduced Nogo-A levels may represent a loss in inputs that would have
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a strong influence on dendritic integration, though further studies would be
needed to confirm this. For example, defining a synaptic populations‘ functional
state requires ultrastructural, electrophysiological, and FM-styryl dye labeling
approaches to locate synaptic assembly, confirm that the neurons are capable of
communication, and identify sites of spontaneous synaptic vesicle recycling,
respectively. Additionally, cross-synaptic immunohistochemistry is needed to
confirm that presynaptic machinery is found in opposition to postsynaptic
structures (Ahmari and Smith, 2002). Interestingly, the percentage of potential
shaft synapses seen in even the control group (19% of total potential synapses) is
higher than would be expected in hippocampal pyramidal neurons of adult rats
and is more typical of a pre-pubertal stage of development (Boyer et al., 1998).
vGlut1 is primarily found in vesicles in nerve terminals, where it aids
glutamatergic transmission. It is widely expressed throughout various brain
regions and layers of the neocortex (Fremeau et al., 2001). While immunogold
labeling has shown the transporter to be present in a small subset of astrocytic
processes, it was estimated to be at a sevenfold lower intensity than that seen in
axon terminals (Bezzi et al., 2004), and thus this background staining seems to
be a minor limitation to accurately identifying potential presynaptic boutons, in
light of other restrictions to defining functional synapses discussed above.
Dendritic neurotransmitter release has been reported in neocortical layers
2/3, and while it is entirely probable that neurons from layer 5 can release
glutamate in a retrograde signaling mechanism, we are unaware of any such
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reports at the time of this writing (Jenstad et al., 2009). Important to the current
study, vGlut1 is not located in dendrites, though vGlut3 is (Fremeau et al., 2004).
Our finding of no changes to the density of vGlut1+ puncta opposing
dendrites of the basilar tree in this same population of neurons is interesting, but
slight differences in Nogo-A regulation between different regions of the dendritic
arbor has been observed in hippocampal dendrites. In the CA1 region, 11C7
treatment led to an increase in basilar dendritic complexity, but no change to
apical complexity. In the CA3, the same treatment led to a decrease in length of
proximal apical dendrites, but an increase in length of distal apical dendrites, and
no change to basilar dendrites (Zagrebelsky et al., 2010). Our finding of no
change to the basilar arbor is also in keeping with our results on spine density
(Chapter 3) and may also account for the unchanged levels in PSD-95 mRNA in
regions of transduced neocortex, since the tissue microdissection attempted to
isolate the deeper cortical layers (Chapter 4). The basilar arbor has both common
and distinct inputs with the proximal apical arbor. In the sensorimotor cortex,
the basilar tree shares inputs from intralaminar layer 5 connections as does the
proximal apical tree, but the basilar arbor also receives input from layer 3
neurons as well (Deuchars et al., 1994; Lubke et al., 1996; Thomson and
Bannister, 1998). Excitatory postsynaptic potential (EPSP) recordings from the
soma of Layer 5 neurons of the frontal agranular cortex have shown that these
connections are associated with different N MDA receptor subunit compositions.
Stimulation via callosal inputs, such as those one would expect from layer 3, that
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have shown to preferentially synapse onto the basilar arbor, was enhanced by an
agent that preferentially promotes inputs from NR2A-containing NMDA
receptors. Conversely, EPSPs elicited from stimulation of local intralaminar
fibers that one could expect to synapse onto both proximal apical and basilar
arbors, were dampened by a NR2B-subunit specific antagonist (Kumar and
Huguenard 2003). Thus, the intracortical and intercortical neurons that have
been shown to synapse onto different regions of the dendritic tree also house
different subunit compositions of the NMDA receptor. Our previous work
(Chapter 4) has shown these same NMDA receptor subunits to be differentially
affected by Nogo-A knockdown. Specifically, we observed a decrease in NR2B
with no substantial change to NR2A subunit expression. It is possible that
postnatal, neuronal Nogo-A may alter dendritic connectivity, in part by
differentially influencing glutamatergic input to the Layer 5 pyramidal neurons.
The changes described here in response to altered levels of Nogo-A
represent a novel function for Nogo-A in influencing potential dendritic shaft
synapses of the apical tree. The presence of Nogo-A within these dendrites and
synapses has been verified by immunohistochemistry and immunoblot of
synaptosomes (Pradhan, 2007; Lee et al., 2008; Grunewald et al., 2009; Raiker
et al., 2010). The decrease in potential dendritic shaft synapses represents a
means by which Nogo-A further regulates stability at the excitatory synapse.
Ultimately, this work aids in our understanding of the functions of this important
therapeutic target in the intact nervous system.

CHAPTER SIX
GENERAL DISCUSSION

This project has demonstrated that postnatal loss of neuronal Nogo-A via
viral-mediated knockdown leads to a statistically significant reduction in the
densities of apical spines on Layer V pyramidal neurons of the sensorimotor
cortex. This same treatment resulted in a third fewer potential excitatory
dendritic shaft synapses seen in opposition to dendrites of these neurons, as
visualized by vGlut1 immunohistochemistry. Postnatal, neuronal Nogo-A
knockdown also resulted in a shift in dendritic spine morphology in the proximal
apical dendrites, including decreases in thin and stable mushroom spines that are
important for learning and memory, respectively. Further alterations in dendritic
spine morphology included fewer protrusions with very long necks when
compared to the control group, and fewer protrusions of moderately-wide
diameter. The decrease in very long spines translates into a population of spines
with less current injection into the parent dendrite. These changes were not
observed in the basilar arbor of the same neurons.
To further investigate the synaptic phenotype of these neurons, regions of
AAV-transduced tissue were examined for changes in mRNA of molecules
fundamental to excitatory synaptic function. Samples of tissue that had received
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Figure 21. Summary of results. EGFP-filled apical dendrites are depicted in
green. The magnitude of the decrease in levels of Neuroligin-1 and NMDA
receptor subunits is much larger than what would predicted by the decrease in
dendritic synapses alone, hence the decreased amount of these molecules at an
individual synapse.

96
AAV-shNogo-A had less Nogo-A when compared to samples from the control
group. We found that knockdown did not significantly alter the amount of NogoB mRNA, which indicates a lack of compensatory coupling with Nogo-B
expression that has been reported in Nogo-A knockout mice (Dimou et al., 2006).
However, the remaining Nogo-B may still confound our results, as it has the
Nogo-66 loop that can signal through NgR1. Both groups examined had similar
levels of PSD-95, but there was a decrease in the relative amounts of Neuroligin-1
and in NMDA receptor subunit NR2B message transcripts in samples lacking
postnatal neuronal Nogo-A when compared to samples from control animals.
There was a trend towards decreased NR2A in Nogo-A knockdown samples, and
mean amounts of NR2A showed a decrease when compared to the control group,
though the change was not statistically significant. Overall, we did observe a
decrease in molecules known to be important at the excitatory synapse, though
some elements of the synapse remained unchanged.
Synaptic structures are key for synaptic plasticity. Decreases in synapse
and spine density and changes to spine morphology lead to disruptions in
information processing. These features, as seen in pyramidal neurons of the
neocortex, are also hallmarks of several neurological disorders, including
Schizophrenia and Alzheimer‘s disease (el Hachimi and Foncin, 1990; Garey et
al., 1998; Fiala et al., 2002a). The time course of spine loss in Alzheimer‘s
disease correlates with the age of symptom onset (el Hachimi and Foncin, 1990;
Scheff et al., 1990; Scheff and Price, 1993; Scheff et al., 1993). Similarly, synapse
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elimination in patients with Schizophrenia peaks at adolescence, and symptoms
typically emerge at late adolescence and early adulthood (Garey et al., 1998).
Schizophrenia and Alzheimer‘s disease are also associated with a decrease in
overall concentrations of NMDA receptors (Penzes et al., 2011).
In the study of mental retardation, Down‘s syndrome is characterized by
decreases in spine density and a reduction in dendritic arbor branching in the
neocortex (Takashima et al., 1981; Takashima et al., 1994). Autism spectrum
disorders are associated with mutations in Neuroligins and their binding
partners, Neurexins, as well as changes to spine density and morphology
(Abrahams and Geschwind, 2008; Dahlhaus and El-Husseini, 2010). Fragile X
syndrome is caused by a loss of Fragile X Mental Retardation Protein (FMRP), a
regulator of protein synthesis which promotes spine growth (Jin et al., 2004;
Belmonte and Bourgeron, 2006). FMRP directs the locations of mRNAs,
including PSD-95, in response to metabotropic glutamate receptor activity (van
Spronsen and Hoogenraad, 2010).
These conditions all have their own characteristic pathophysiology, but
show these similar changes in synaptic features. These features are also seen in
the neocortex after postnatal Nogo-A knockdown, raising the question of a shared
underlying molecular pathway. Rho GTPases are regulators of the actin
cytoskeleton, spine and synapse development, and Nogo-A signaling (Tashiro
and Yuste, 2004; Lippman and Dunaevsky, 2005; Calabrese et al., 2006). One
of the main candidate genes in the Down‘s syndrome critical chromosomal region
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regulates neuronal differentiation via RhoA (Berto et al., 2007). Three of the
thirteen genes known to be associated with X-linked mental retardation encode
for Rho GTPases (Ramakers, 2000; Chelly and Mandel, 2001; Negishi and Katoh,
2002; Govek et al., 2005; Nadif Kasri et al., 2009). At least two Rho GTPases
and one Rho GAP have been linked to Schizophrenia (Davidkova et al., 2003;
Hashimoto et al., 2005; Hill et al., 2006). A thorough behavior analysis of NogoA knockout mice has revealed an increase in Schizophrenia-like behavior, with
alterations in startle response, perseverative behavior, and increased sensitivity
to the locomotor stimulating effects of amphetamine (Willi et al., 2009; Willi et
al., 2010). These changes were not seen in adult wild-type mice that had received
anti-Nogo-A antibody treatment, suggesting that this phenotype is a product of
alterations in development (Willi et al., 2010). Further work examining RhoA
and synaptic stabilization may help understand the connections between these
conditions, and eventually aid in the development of therapies for affected
individuals.
The decrease in dendritic spines seen here after postnatal Nogo-A
knockdown stands in contrast to our laboratory‘s previous finding of increased
spine density after middle cerebral artery occlusion and Nogo-A immunotherapy
(Papadopoulos et al., 2006). There are several possible reasons for this: (1) In
the present project, the Nogo-A knockdown was delivered at postnatal day 3,
while anti-Nogo-A immunotherapy was given to an adult animal; therefore the
age which Nogo-A signaling was disrupted could account for the different results
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in spine density. (2) Nogo-A may have different signaling mechanisms from
different cellular compartments, and while the knockdown targeted all Nogo-A
molecules in the neuron—those at the surface as well as the ER—the antibody
treatment was only able to affect the relatively small proportion of Nogo-A
molecules that were at the plasma membrane. Finally, (3) oligodendrocyteassociated Nogo-A was still present in the knockdown paradigm but not in the
immunotherapy treatment. Our Nogo-A knockdown primarily targeted neurons,
and the presence of Nogo-A in other cell types such as oligodendrocytes may have
resulted in the differences between this project and our earlier study
(Papadopoulos et al., 2006).
We attempted a pilot study to determine if Nogo-A knockdown led to a
behavioral change that could be measured using standard tests of rodent
behavior. In this regard, postnatal Nogo-A knockdown in the sensorimotor
cortex and hippocampus did not affect spatial navigation or swim speed as
measured using the Morris water maze (Appendix). This may be due to several
possible reasons. First, AAV-delivery was targeted to a large region of
hippocampus, and the viral transduction was simply too low, or did not cover
enough of the extent of the dorso-ventral axis. Groups examining other gene
targets have found cognitive measures of behavior after AAV-mediated gene
delivery, though injection was limited to nuclei or small regions of the brain (Bahi
et al., 2009; Alexander et al., 2010; Spiteri et al., 2010). Similarly, non-cognitive
changes to coordination were observed after injecting AAV containing a gene for
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a neurotrophic factor into large regions of the cerebral cortex (Airavaara et al.,
2010). It is also possible that the lack of changes seen to spatial navigation
behavior in our study is the fact that Nogo-A may have a relatively minor role at
the synapse, compared to essential components of vesicular release machinery
such as voltage-gated calcium channels, or SNARE proteins, for example.
Overexpression of the botulism target SNAP-25 in the adult hippocampus via
AAV leads to memory impairment via Morris water maze despite only 8%
transfection efficiency (McKee et al., 2010). However, while we did not count
cells to assess transduction efficiency, the density of EGFP-positive cells in our
work was comparable to the number of neurons stained for a Golgi reaction,
which would be approximately 1% of neurons. If our efficiency of transduction
had been higher or more uniform, we anticipate postnatal Nogo-A knockdown
would have affected spatial navigation or locomotion on the Morris water maze.

FUNCTION OF NEURONAL NOGO-A IN PYRAMIDAL NEURONS
Postsynaptic Nogo-A signaling
Together, these results show that loss of neuronal Nogo-A in postnatal
development leads to a decrease in synaptic structures and associated molecules.
These findings are in keeping with the hypothesis that Nogo-A functions to
maintain synaptic structures, a hypothesis that has recently been demonstrated
in other cell types. In the developing PNS, Nogo-A-mediated facilitation of
neurite branching (Petrinovic et al., 2010). Nogo-A knockout or blockade by 11C7

101
anti-Nogo-A antibody lead to increased neurite length and decreased branch
formation in DRG dissociated cultures. DRG explant cultures exposed to the
same treatments showed increased length and fasciculation of neurites.
Blockade of NgR, Lingo1, or ROCK produced similar results in both cell culture
systems. In the embryonic hindlimb, injection of 11C7 led to axons that failed to
grow out from the plexus area or formed aberrant pathways that did not extend
through the full area of the limb, while injection of control antibodies did not
alter peripheral nerve formation. Nogo-A knockout mouse embryos show
decreased length and width of hindlimb nerves (Petrinovic et al., 2010). The
addition of 11C7 antibodies to hippocampal slice cultures led to decrease in apical
complexity in CA3, but a decrease in complexity in the basilar tree of neurons of
the CA1. This treatment also led to an increase in the density of stubby spines in
the apical tree of CA3 pyramidal neurons (Zagrebelsky et al., 2010).
Nogo-A and its receptor NgR1 are present at both the pre and postsynaptic
structures in cortical pyramidal neurons (Pradhan, 2007; Grunewald et al., 2009;
Raiker et al., 2010). We can be sure of loss of Nogo-A at the postsynaptic
structure because shNogo and EGFP were expressed on the same plasmid. We
did not observe EGFP-filled fibers synapsing onto or intersecting the dendrites
examined, but we can not exclude the possibility of Nogo-A knockdown on the
presynaptic terminal as the majority of neurons expressed EGFP only at the soma
and not in their dendrites or axons (Fig. 5, 6). As such, Nogo-A may or may not
have been expressed at the presynaptic terminal (Fig. 23). This may be remedied
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Figure 22. Model for synaptic stabilization via Nogo-A. Neuronal NogoA may signal through NgR1 or integrins. Dark arrows indicate signal pathways
Nogo-A is known to activate in neurons. Grey arrows indicate pathways that
have been shown in other neuronal signaling cascades. Activated forms of
molecules are shown in black, inactive forms are shown italicized, in grey. Inset
shows area enlarged. ―?‖ indicates an outcome seen in response to Integrins in
other neuronal contexts, but have not been reported in Nogo-A/Integrin
signaling pathways. See p. xiv for abbreviations.
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Figure 23. Potential mechanism by which Nogo-A knockdown
destabilizes synapses. Loss of postsynaptic Nogo-A induced NgR1 and
Integrin signaling can lead to a loss of synapse-stabilizing signaling schemes,
including the inactivation of Cofilin via phosphorylation. Nogo-A in axon
terminal is indicated by a dashed line signifying it may or may not be deleted in
our knockdown paradigm (see text). Inset indicates a lower magnification of the
region that has been enlarged.
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in future studies by use of a stronger, more persistent promoter.
The possibility of Nogo-A signaling through an autocrine mechanism may
contribute to the findings described here. Nogo-A-mediated activation of NgR1
can mediate growth cone collapse through increasing actin contractility by way of
RhoA/ROCK-mediated activation of Myosin II. Nogo-A induced RhoA/ROCK
activation is also known to activate LIM kinase (LIMK), which in turn inactivates
Cofilin by phosphorylation. This inactivation of Cofilin blocks its ability to sever
the negative end of F-actin filaments, which slows actin turnover and helps create
an environment of synaptic stability. The LIMK-Cofilin mechanism of Nogo-A
signaling may account for some of our results (Figs. 22, 23). However, Cofilin is
only one of many actin-binding proteins, so additional signaling pathways may be
responsible for our results. Amino-Nogo-A has demonstrated the ability to signal
through integrins, which are known to mediate synaptic and spine stability
through actin cytoskeleton dynamics (Gerrow and El-Husseini, 2006; Shi and
Ethell, 2006; Webb et al., 2007; Cingolani and Goda, 2008; Hu and Strittmatter,
2008; Carlson et al., 2010).
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Growth cone collapse vs. dendritic stabilization
Differences in Nogo-A induced signaling cascades may account for how
reduction of an axonal inhibitory molecule (Fig. 1) can decrease spine density and
expression of synaptic molecules (Fig. 23), when one would initially expect an
increase in these latter parameters. At sites of established neuronal-neuronal
contact, Nogo-A may stabilize the cytoskeleton through RhoA/LIM kinase/Cofilin
mechanism. At the axonal growth cone, oligodendrocyte or neuronal Nogo-A
communicates through RhoA/MLCK/MyosinII pathway to stabilize actin and
thereby halt growth cone advancement. A careful review of the literature
demonstrates that other axonal inhibitory molecules have also demonstrated the
phenomenon of promoting dendritic sprouting and plasticity, such as ephrinB3,
semaphorin 3A, Slit1, and Netrin-1. Various mechanisms have been proposed to
account for this. In the case of the axonal outgrowth inhibitor ephrinB3, earlier
reports had established mechanisms that can modulate their signaling such as
forward/reverse signaling between ephrins and their ‗receptors,‘ the Ephs (Aoto
et al., 2007). For semaphorin3A, a guanylate cyclase gradient appears to govern
the nature of the response so it can inhibit axonal outgrowth and still promote
dendritic branching (Polleux et al., 2000; Morita et al., 2006).
Some axon guidance molecules have multiple effects dependent on which
of its many known receptors the molecule encounters. For example, the axon
guidance cue Slit1 can promote dendritic growth (Whitford et al., 2002), but it is
also known to repel or attract axons based on the presence of different robo

106
receptors the axon encounters. Likewise, Netrin-1, which promotes dendritic
growth (Suli et al., 2006), helps axons cross the CNS midline in embryonic
development because it can be attractive toward the midline prior to crossing and
repulsive once the axon has crossed the midline, based on the presence of a
matrix metalloprotease that truncates DCC receptors (Galko and Tessier-Lavigne,
2000). The Netrin-1 molecule can also signal through Unc5h receptors, which
inhibit axonal growth cones (Hong et al., 1999).
The mechanisms by which some molecules control dendritic development
are yet to be discovered. For example, manipulations of Neurotrophin-3 levels
can lead to opposing effects of dendritic growth in different cortical layers.
Specifically, Neurotrophin-3 appears to negatively regulate dendritic branching
in layer 4 and promote branching in layer 6 (McAllister et al., 1997). Further
studies are needed to confirm the molecular mechanisms (Fig. 22) whereby
Nogo-A can simultaneously stabilize dendritic synapses and destabilize growth
cones in the injured CNS.

FUTURE DIRECTIONS
One of the most valuable studies of this system would be studies to clarify
the molecular mechanisms responsible for the decrease in spines and synaptic
molecules seen in response to reduction in neuronal Nogo-A. To study the
proposed neuronal Nogo-A signaling pathways (Figs. 22, 23), a neuron primary
culture model would be ideal. If plated at ideal density, many synaptic features
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that are seen in vivo can also be seen in vitro, including dendritic spines (Murphy
and Andrews, 2000; Vicario-Abejon, 2004). The first experiment needed to
confirm the proposed mechanisms would be demonstration that Nogo-A
knockdown destabilizes actin, which could be confirmed by an F/G-actin ratio
assay. This would also be more useful as a more economical, non-anatomical
endpoint than spine analysis or staining of synapse-associated proteins. Because
the F/G-actin ratio can also be examined in vivo, this assay could also be used in
our in vivo model to confirm that cell culture transfection model has similar
traits.
If the F/G actin ratio could be used as a reliable endpoint of Nogo-Amediated signaling, subsequent experiments might use a double-transfection
technique with plasmids containing different fluorescent markers for different
receptors and downstream effectors. Additionally, NgR1 antibodies, ROCK
inhibitors, cofilin inhibitory peptide, and Rho-A inhibitors could be employed to
tease out the signaling pathways involved. Other endpoints such as pull-down
assays or a RhoA G-LISA activation assay would be useful means to examine
Nogo-A signaling.
The validation of this model and these results by a second virus that would
target a different region of Nogo-A is a second potential direction. Also, a
tetracycline or doxycycline on/off system would be excellent means to study if
these effects are due to spine and synaptic maintenance or developmental
windows that regulate these properties. Recently, the Schwab lab has developed
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a line of Nogo-A knockout rats that are currently under investigation. This line
has miRNA directed against Nogo-A expressed in nearly all neurons, and a
comparison of our two models would be a good way to study the effects of
intracellular vs. intercellular-acting Nogo-A.
It would also be interesting to investigate the role of Nogo-A at the
inhibitory synapses of these neurons, although this line of inquiry does less to
address the mechanisms at hand. This could be examined by
immunohistochemistry of gephryn and GABA transporters, although
ultrastructural analysis would be a better means to study structural changes. As
with excitatory connections, FM-styryl dye cycling and electrophysiology studies
are needed in addition to fluorescent imaging methods, to completely describe a
molecule‘s effect on synapses.

APPENDIX:
PILOT EXPERIMENTS
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APPENDIX: PILOT EXPERIMENTS
SPATIAL MEMORY TESTING FOLLOWING NOGO-A SILENCING
IN THE POSTNATAL RAT HIPPOCAMPUS

RATIONALE
Synapses have been postulated to be the physical sites where molecular
memory mechanisms, such as those required for LTP, are housed (Segal, 2005).
A well-studied and practical paradigm to examine memory is the Morris water
navigation test, although this behavioral test assesses changes on a much broader
scale than the molecular level of a single synapse. Nonetheless, studies involving
the Morris water maze and LTP paradigms have frequently shown the two results
correlate with changes in spine density (Morris et al., 1986; Tang et al., 2001;
Eyre et al., 2003; Segal, 2005; Lee et al., 2008). Furthermore, it has previously
been shown that Nogo-A immunotherapy results in improved cognitive recovery
following CNS lesions (Lenzlinger et al., 2005; Gillani et al., 2010). Therefore, we
assessed the effect of postnatal Nogo-A silencing in the hippocampus on spatial
navigation, to determine if neuronal Nogo-A is required for development of the
cognitive capabilities required for the Morris water maze.
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METHODS
Husbandry
P3 male rat pups were cryoanesthetized and injected with AAV2/8, as
described in chapter 3. Vehicle rats treated identical to AAV-injected rats, except
they received injections of sterile PBS. Vehicle injected, AAV-EGFP, AAVZsgreen-shLuciferase, and AAV-EGFP-shNogo groups were comprised of 10, 14,
14, and 15 rats, respectively. Morris water navigation testing commenced on P52.
This study was conducted using protocols approved by the Edward Hines Jr. VA
Hospital Institutional Animal Care and Use Committee in accordance with
National Institutes of Health principles of laboratory animal care.

Morris water navigation testing
Place testing consisted of four trials per day, for six consecutive days, with
each trial separated by at least 10 minutes. A 6‘ diameter pool was filled with
22˚C water, made opaque by addition of white tempera paint. A white, 2‖ square
platform was submerged 2 cm below the surface of the water. Starting locations
were randomized daily. The rat was gently lowered into the pool, facing the
inside wall of the pool, and allowed to swim until he found the platform or until
two minutes had expired.
One probe trial was performed, on day seven. This testing procedure was
identical to hidden platform testing, except that the platform had been removed
from the pool. Each rat swam for two minutes.
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Matching-to-Place testing occurred over five consecutive days (days eighttwelve), in which the rat was introduced to the pool twice a day, with 20 seconds
between trials. The location of the hidden platform changed daily, in a
randomized manner. The rat was allowed three minutes to find the platform.
For each test, swim paths were digitized by Noldus Ethovision Software.
Place and Matching-to-place paths were analyzed for trial time, total distance
traveled, swim velocity, thigmotaxis, and route circuitry. Trial time, total
distance traveled, and average swim velocity were determined for each trial by
Noldus Ethovision. This software was also used to measure thigmotaxic
behavior, by defining an inner and outer portion of the pool, and recalculating
the distance traveled in each region. Route circuitry was calculated as the
quotient of total distance traveled divided by the displacement distance from the
trial starting point to the nearest edge of the hidden platform.
Place task paths were also analyzed for the degree of heading direction
error within the first 5 seconds of each trial. Heading direction error was
investigated using Oriana circular statistics program by first assessing angular
variance (r) for each rat over the first six days of the Place task. Angular variance
ranges from 0 to 1, with 0 indicating random heading direction, and 1 indicating
all heading angles point to the same direction. Among groups where angular
variance was equal, we then generated a mean heading direction angle for each
rat on each day of the Place task, and then compared mean heading direction
angles for each day across groups.
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Statistics
For the Probe trial, the preference score, P = [(T-A) + (T-B) + (T-C)]/3,
was calculated as in (Brown et al., 2000), and analyzed by ANOVA with Tukey
post-hoc testing (Graphpad). Mean heading direction angles were compared
using the Watson-Williams F test in Oriana (Wallace et al., 2002). All other data
was analyzed by repeated-measures ANOVA with Tukey post-hoc testing (SPSS).
In all cases, p > 0.05 was regarded as significant.

RESULTS
Postnatal, neuronal Nogo-A knockdown as described here does not lead to
impairment in short or long term spatial memory, as measured by the Morris
water maze place (p = 0.22 for distance traveled and p = 0.82 for latency to find
the platform, App. Fig. 3) and matching-to place tests (p > 0.99 for time to find
the platform during the second trial, App. Fig. 5), respectively. No differences
were observed with regards to swim velocity on the place test (p = 0.34, App. Fig.
4). Similarly, no significant differences were observed between groups in the
probe trial (p = 0.98) or thigmotaxic behavior (p = 0.80). Furthermore,
navigation strategies appear to be unchanged, as determined by route circuitry
and heading direction analysis (data not shown).
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App. Figure 1. Experimental design, including behavioral testing and
swim paths representative normal animals on select testing days.
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App. Figure 2. Hippocampal neuron transduction with AAV2/8.The
green color indicates a virally transduced neuron (EGFP). Note the layer of
transduced pyramidal neurons in the CA1 region. Pictures were taken at 5x, 20x,
and 63x magnification. 63x photos were taken on scanning confocal microscope.
Scale bars indicate 10 microns. Adapted from Paxinos and Watson, 2006.
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App. Figure 3. Long-term memory performance on the Morris water
maze place task. No significant differences were observed between groups for
(A) time or (B) distance traveled per trial. Data pooled from 10 (Vehicle), 14
(EGFP), 14 (shLuc), and 15 (shNogo) animals per group. Error bars indicate
SEM.
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App. Figure 4. Short-term memory performance on the Morris water
maze matching-to-place task. No significant differences were observed
between groups for the time it took to find the platform for either Trial 1 or Trial
2. Data pooled from 10 (Vehicle), 14 (EGFP), 14 (shLuc), and 15 (shNogo)
animals per group. Error bars indicate SEM.
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App. Figure 5. Swimming velocities were not significantly different
between treatment groups. Data pooled from 10 (Vehicle), 14 (EGFP), 14
(shLuc), and 15 (shNogo) animals per group. Error bars indicate SEM.
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CONCLUSION
Previous reports have noted a change to cognitive behavioral testing
following CNS injury and Nogo-A immunotherapy (Brenneman et al., 2008;
Gillani et al., 2010). While the results here do not support the hypothesis that
Nogo-A is required for development of spatial memory, there are a few points to
consider. First, interpretation is limited by the fact that the virus did not
transfect the entire hippocampus (App. Fig. 2), and redundancy within the
structure may compensate for any loss in function. Second, the behavioral test
may not be sensitive enough to detect changes that may have occurred in this
system on a molecular scale. Third, the peak of Schaffer collateral synaptogenesis
at P7 would fall earlier than the expected peak in AAV2/8 expression in the CNS
at P17 or later (Reimsnider et al., 2007). As such this experiment does not
address the potential role of synaptogenesis, merely the possibility of Nogo-A in a
maintenance role in later postnatal development.
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APPENDIX: PILOT EXPERIMENTS
HIPPOCAMPAL SPINE DENSITY AND MORPHOLOGY FOLLOWING
NOGO-A SILENCING IN THE POSTNATAL RAT

RATIONALE
Given our result of decreased spine density in the pyramidal neurons of
the sensorimotor cortex, we sought to examine the pyramidal neurons of the
hippocampus due to several similarities between the two neuronal populations.
Both sets of excitatory pyramidal neurons have been well-studied as models of
synaptic plasticity. Additionally, both populations show similar Nogo-A
expression patterns, with high levels of protein expressed in development and
lower levels in adulthood (Meier et al., 2003; Hasegawa et al., 2005). As such,
hippocampal neurons appeared ideally suited for studies on the effect of Nogo-A
in spine density and morphology.
The striatum radiatum is a band running throughout the hippocampus
that houses the proximal dendrites of the pyramidal neuron‘s apical tree. A
single neuron in the CA1 region receives inputs from as many as 5000 axons
traveling through Schaffer collateral pathway, originating in the CA3 region of the
hippocampus (Kandel, 2000). We found no change in spine density and a
decrease in filopodial spine morphology following postnatal, neuronal Nogo-A
knockdown.
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METHODS
Rats that had been injected at P3 and had been examined for behavioral
deficit by Morris water maze (App., above) were used for this study. An inclusion
criterion was based on neuron transduction, as assessed by EGFP. AAV-EGFP
and AAV-shNogo groups were comprised of 8 and 7 rats, respectively. Spines
were analyzed as also described in Chapter 3, with the exception that dendrites
were imaged in the striatum radiatum from pyramidal neurons of hippocampal
region CA1.

RESULTS
Spine density and morphology in the Hippocampal CA1 region
following loss of postnatal, neuronal Nogo-A
Nine weeks after AAV delivery, no changes in spine density were observed
between groups (p = 0.27, App. Fig 6A). A 53% decrease in filopodia-type
protrusion density was seen in AAV-shNogo group (1.3 ± 0.2 filopodia/10 µm
dendrite), when compared to the AAV-EGFP group (0.7 ± 0.1 filopodia/10 µm
dendrite, p = 0.02, App. Fig. 6B). However, no other changes in spine
morphology were observed between groups, including measurements of spine
length (0.89 µm ± 0.05 for AAV-EGFP and 1.00 µm ± 0.10 for AAV-shNogo, p =
0.29) and head diameter (0.59 µm ± 0.03 for AAV-EGFP and 0.62 µm ± 0.03 for
AAV-shNogo, p = 0.50).
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App. Figure 6. Hippocampal CA1 region spine density and
morphology following postnatal loss of Nogo-A. (A) No substantial
differences were observed in spine density. (B) A decrease in filopodia-type
protrusions was observed. Data pooled from 8 (EGFP) and 7 (shNogo) animals
per group. Error bars indicate SEM, * indicates p < 0.05, two-tailed Student‘s ttest
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CONCLUSIONS
The region of the dendritic arbor studied here, apical segments at least 100
µm distal to the soma, has been shown to be more sensitive to changes in spine
density and morphology (Gould et al., 1990; Pyapali and Turner, 1994). We also
targeted both populations of neurons involved at the CA1 spine for Nogo-A
knockdown. Nevertheless, our finding of no change to spine density in the
postnatal hippocampus following Nogo-A knockdown is in keeping with similar
work in the adult following blockade of Nogo-A (Zagrebelsky et al., 2010) and
NgR1 (Lee et al., 2008).
The reported spine density of CA1 neurons of the intact adult, male rat
ranges from 9 spines/10 micrometers of dendrite (Knafo et al., 2004) to more
than twice the density we have seen here, as assessed by the Golgi method
(Norrholm and Ouimet, 2000; Gonzalez-Burgos et al., 2004; Stranahan et al.,
2008) and DiI labeling (Cunningham et al., 2007). In an effort to transfect as
many neurons as possible, in the hopes of seeing behavioral effects, it is possible
that we may have raised the background level to the point where signal was lost
to high background noise.
One possible reason for similar spine densities between groups may be the
remaining levels of Nogo-B (Chapter 4). Nogo-B, like Nogo-A, can signal through
NgR1 via the Nogo-66 loop. Inducible, Nogo-A/B knockout models may aid in
future investigation of neuronal Nogo-A signaling in postnatal development.
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APPENDIX: PILOT EXPERIMENTS
DENDRITIC MORPHOLOGY AND SPINE DENISTY IN THE
FORELIMB SENSORIMOTOR CORTEX OF NOGO-A KNOCKOUT
MICE

RATIONALE
Alterations in dendritic plasticity have been shown in response to Nogo-A
antibody therapy in rats that had received middle cerebral artery occlusion, an
experimental model of stroke (Papadopoulos et al., 2006). Naïve rats that receive
the same antibody regimen demonstrate transient changes to spine density
(Papadopoulos et al., 2006). Similarly, cultured neocortical neurons of Nogo-A
knockout mice display altered neurite morphology (Mingorance-Le Meur et al.,
2007), and the dendritic structure of hippocampal neurons is altered in response
to Nogo-A knockout, knockdown, and antibody occlusion (Zagrebelsky et al.,
2010).
We chose to examine the dendritic structure of neocortical neurons of
Nogo-A knockout mice that had over 10 generations of backcrossing to the
129X1/SvJ strain. This rigorous backcrossing reduces experimental variation by
eliminating genetic influence of the C57BL/6 strain. 129X1/SvJ Nogo-A
knockout mice differ from Nogo-A knockout mice with C57BL/6 genetic
background in that the former strain has a slight increase in regenerative
potential, and a reduced immune response after injury (Dimou et al., 2006).
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METHODS
Golgi-Cox Staining and Analysis
Adult Nogo-A knockout mice that had been backcrossed to the 129X1/SvJ
line were anesthetized with an overdose of pentobarbital, transcardially perfused,
and their brains were prepared for Golgi-Cox stain. After coronal slicing at 200
µm on a vibratome, brains were stained and coverslipped as previously described
as in (Gibb and Kolb, 1998; Papadopoulos et al., 2006). Large pyramidal
neurons from the forelimb sensorimotor cortex were located in layer V by
morphology and with the aid of a mouse stereotaxic brain atlas (Paxinos and
Franklin, 2001). Neurons that were intact, unobstructed, and fully impregnated
were traced via camera lucida (see App. Fig. 7 for representative tracings). Five
neurons were traced per animal, for a total of seven mice in the wild-type group
and eight mice for the Nogo-A knockout group.
Dendritic length was approximated via the Sholl method, which counts the
number of lines that intersect a series of concentric circles. Dendritic complexity
was calculated by counting the total number of branch points for each arbor. For
spine density analysis, the number of protrusions was counted for a 50 µm length
of dendrite.

Statistical Analysis
Data was analyzed by two-tailed Student‘s t-test. In all cases, p > 0.05 was
regarded as significant.
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RESULTS
Nogo-A knockout mice were similar to wild-type mice with regards to total
dendritic arbor length (1537 ± 270 µm of dendrite for EGFP and 1465 ± 167 µm, p
= 0.66). We divided this data into apical (556 ± 72 µm of dendrite for wild-type
and 532 ± 75 µm for knockout, p = 0.69) and basilar arbor (981 ± 224 µm of
dendrite for wild-type and 933 ± 164 µm for knockout, p = 0.70, App. Fig. 8)
compartments and saw no differences between groups. Also, the complexity of
the apical and basilar dendritic trees displayed no change between wild-type and
Nogo-A knockout neurons (App. Fig. 9).
There was a slight trend toward increased average spine density in the
Nogo-A knockout animals when examining both the apical and basilar
compartments together (7.9 ± 2.1 spines per 10 µm dendrite for wild-type and 9.0
± 1.9 spines per 10 µm for knockout, p = 0.08). We further broke this data down
into apical (8.5 ± 2.5 spines per 10 µm dendrite for EGFP and 8.0 ± 2.0 spines
per 10 µm for Nogo-A knockout, p = 0.25) and basilar (7.9 ± 1.5 spines per 10 µm
for EGFP and 8.5 ± 1.8 spines per 10 µm for knockout, p = 0.16, App. Fig. 10)
compartments and saw no significant differences between groups.
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App. Figure 7. Representative Layer V pyramidal neuron tracings for
wild-type and Nogo-A knockout mice. Small numerals next to dendrites
indicate the branch order. Each time the dendrite split, both branches were
counted for dendritic complexity analysis.
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App. Figure 8. Average length of dendrites in Layer V pyramidal
neurons of Nogo-A knockout mice. Length of dendritic trees was analyzed
total arbor and by apical and basilar compartments. Results were similar
between groups. Data pooled from 7 (wt) and 8 (KO) animals per group. Error
bars indicate SEM.
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App. Figure 9. Dendritic complexity of Nogo-A knockout mice.
Dendritic bifurcation was similar between groups, at any level of branch order
analyzed (two-tailed Student‘s t-test analyzed at each branch order point). Data
pooled from 7 (wt) and 8 (KO) animals per group. Error bars denote SEM.
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App. Figure 10. Spine densities of Nogo-A knockout mice neurons of
the neocortex. (A) Representative segment of Golgi-Cox stained dendrite. (B)
Shown are the average spine densities per all dendritic segments, and for the
apical and basilar arbors. No significant differences were observed between
groups. Data pooled from 7 (wt) and 8 (KO) animals per group. Error bars
denote SEM.
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CONCLUSION
We observed a slight trend of increased spine density in the Nogo-A
knockdown group when compared to wild-type mice, though the p value did not
cross the 0.05 threshold. No significant differences were observed in gross
dendritic structure, as assessed by length of dendrites or number of branches at
any order.
It is important to note that this model targets Nogo-A from all cell types,
and at all stages of development. The use of mutant mice to study the effects of
Nogo-A has created controversy for nearly eight years (Woolf, 2003; Teng and
Tang, 2005). Recently two of the three investigators that originally developed
Nogo knockout mice have questioned the use of these animals to study CNS
injury (Tuszynski and Schwab, 2010). The challenges mainly center on effects of
genetic background, the continued presence of other inhibitory molecules such as
ephrin and semaphorin, and developmental compensation. For example, a twofold upregulation of Nogo-B protein in these animals may be a form of
compensatory response to the genetic deletion of Nogo-A (Dimou et al., 2006).
Phenotypically, Nogo-A knockout mice with C57BL6 genetic background
display alterations in midbrain dopaminergic signaling and schizophrenia-like
behavior (Willi et al., 2010). Nogo-A/B knockout mice have shown delayed
closure of the optical dominance critical period (McGee et al., 2005). While we
have not observed significant, large-scale changes in plasticity at the level of
dendritic architecture, it is possible that further segregation of spines into midand distal-apical trees would reveal changes in density, such as seen in the CA1

[132]
neurons of Nogo-A knockout mice with the C57BL/6 genetic background
(Zagrebelsky et al., 2010). Furthermore, alterations in neuronal plasticity in the
neocortex may be detected by methods other than gross structural features, or
may only be observable at certain stages of development. Future studies in this
area would benefit from addressing these possibilities as well as a combination of
Nogo-A knockdown rats and antibody therapies directed against Nogo-A.
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